A. Mark Richards
#99,008
Most Influential Person Now
Cardiovascular researcher in New Zealand
A. Mark Richards's AcademicInfluence.com Rankings
A. Mark Richardsmedical Degrees
Medical
#1137
World Rank
#1445
Historical Rank
Cardiology
#72
World Rank
#73
Historical Rank
Download Badge
Medical
A. Mark Richards's Degrees
- Bachelors Biology University of Auckland
- Masters Biomedical Science University of New Zealand
- PhD Cardiovascular Research University of New Zealand
Similar Degrees You Can Earn
Why Is A. Mark Richards Influential?
(Suggest an Edit or Addition)According to Wikipedia, Arthur Mark Richards is a New Zealand physician, academic and medical researcher. He is a professor of cardiology and director of the Cardiovascular Research Institute at the National University of Singapore, and a professor of medicine and founder of the Christchurch Heart Institute at the University of Otago, Christchurch, New Zealand, where he holds the National Heart Foundation Chair of Cardiovascular Studies.
A. Mark Richards's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations (2000) (1414)
- NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. (2006) (1029)
- Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. (1998) (724)
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment (1997) (549)
- Plasma brain natriuretic peptide in assessment of acute dyspnoea (1994) (527)
- Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. (2010) (485)
- B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction (2003) (450)
- RENAL, HAEMODYNAMIC, AND HORMONAL EFFECTS OF HUMAN ALPHA ATRIAL NATRIURETIC PEPTIDE IN HEALTHY VOLUNTEERS (1985) (431)
- Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. (2003) (393)
- 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. (2012) (390)
- Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. (2001) (361)
- N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. (2009) (342)
- Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. (1993) (339)
- Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations (2019) (335)
- Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. (2007) (335)
- Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis (2003) (322)
- Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. (2004) (280)
- Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. (2013) (279)
- A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study (2011) (271)
- Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. (1986) (266)
- Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure (2010) (261)
- Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. (2003) (256)
- Biology of the natriuretic peptides. (2008) (242)
- Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis (2014) (241)
- The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. (1995) (237)
- Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. (1999) (234)
- Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. (2005) (233)
- A landscape of circular RNA expression in the human heart (2017) (228)
- Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease (2011) (228)
- Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. (1993) (226)
- Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis. (2017) (214)
- Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. (2003) (203)
- Coenzyme Q10: an independent predictor of mortality in chronic heart failure. (2008) (200)
- Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction (1999) (196)
- Bioactivity and metabolism of C-type natriuretic peptide in normal man. (1994) (194)
- Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. (2006) (184)
- Effects of ACTH and Cortisol Administration on Blood Pressure, Electrolyte Metabolism, Atrial Natriuretic Peptide and Renal Function in Normal Man (1987) (184)
- Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. (1993) (182)
- A Test in Context: Neprilysin: Function, Inhibition, and Biomarker. (2016) (178)
- Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study (2014) (178)
- Right ventricular dysfunction in left‐sided heart failure with preserved versus reduced ejection fraction (2017) (178)
- Plasma alpha natriuretic peptide in cardiac impairment. (1986) (178)
- Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study (2018) (177)
- Growth differentiation factor 15, ST2, high‐sensitivity troponin T, and N‐terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction (2012) (177)
- Plasma urotensin II in heart failure (2002) (176)
- Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study. (2015) (174)
- A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. (2014) (167)
- Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction (2015) (166)
- Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients (2013) (159)
- Amino-terminal pro-brain natriuretic Peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? (2006) (159)
- Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated Copeptin: Secondary Results From the Biomarkers in Acute Heart Failure (BACH) Study (2011) (156)
- BLOOD-PRESSURE RESPONSE TO MODERATE SODIUM RESTRICTION AND TO POTASSIUM SUPPLEMENTATION IN MILD ESSENTIAL HYPERTENSION (1984) (150)
- Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF (2016) (149)
- Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance (2016) (146)
- Natriuretic hormones. (1995) (141)
- Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial (2012) (140)
- Obstructive Sleep Apnea and Cardiovascular Events After Percutaneous Coronary Intervention (2016) (139)
- Effects of alpha-human atrial natriuretic peptide in essential hypertension. (1985) (138)
- Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. (2003) (135)
- Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. (2007) (135)
- Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. (1989) (132)
- Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. (1997) (131)
- Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients: Initial Experience With a New Permanent Implantable Device (2007) (129)
- Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction (2016) (126)
- Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. (2001) (125)
- Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. (2011) (123)
- Introduction of Metoprolol Increases Plasma B-Type Cardiac Natriuretic Peptides in Mild, Stable Heart Failure (2006) (122)
- Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry. (2016) (122)
- Antecedent hypertension and heart failure after myocardial infarction. (2002) (120)
- Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep. (1996) (119)
- Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study (2019) (115)
- Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure. (2003) (115)
- Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. (2002) (115)
- NT‐proBNP in heart failure: therapy decisions and monitoring (2004) (114)
- Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. (1998) (114)
- Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. (1986) (113)
- The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure. (2000) (112)
- Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis (2016) (111)
- Brain natriuretic peptide administered to man: actions and metabolism. (1990) (110)
- Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. (2010) (109)
- Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. (1988) (109)
- Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta‐analysis † (2012) (107)
- Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). (2013) (107)
- Comprehensive standardized data definitions for acute coronary syndrome research in emergency departments in Australasia (2010) (106)
- The neuro‐cardio‐endocrine response to acute subarachnoid haemorrhage (2002) (105)
- Iron deficiency in a multi‐ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis (2014) (104)
- Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. (2006) (104)
- Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. (1996) (103)
- Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. (2005) (102)
- Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. (2000) (101)
- Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. (2018) (101)
- Adrenomedullin: a hypotensive hormone in man. (1997) (100)
- Effectiveness of EDACS Versus ADAPT Accelerated Diagnostic Pathways for Chest Pain: A Pragmatic Randomized Controlled Trial Embedded Within Practice. (2016) (100)
- Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase. (2000) (99)
- Severe obstructive sleep apnea and outcomes following myocardial infarction. (2011) (98)
- Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry (2018) (98)
- MicroRNA and Heart Failure (2016) (97)
- Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods. (1987) (97)
- Heart failure with preserved ejection fraction in Asia (2018) (95)
- Which heart failure patients profit from natriuretic peptide guided therapy? A meta‐analysis from individual patient data of randomized trials (2015) (94)
- Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects. (1990) (94)
- Urocortin-1 infusion in normal humans. (2004) (93)
- Cardiac natriuretic peptides for cardiac health. (2005) (93)
- Correlates of plasma atrial natriuretic factor in health and hypertension. (1987) (92)
- Urocortin 2 infusion in human heart failure. (2007) (92)
- Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated CopeptinClinical Perspective (2011) (92)
- Integrated Hemodynamic, Hormonal, and Renal Actions of Urocortin 2 in Normal and Paced Sheep: Beneficial Effects in Heart Failure (2005) (92)
- The importance of the renin-angiotensin system in cardiovascular disease (1998) (92)
- Severe hypertension and raised haematocrit: unusual presentation of Guillain-Barré syndrome. (1985) (91)
- The Role of the Circulation in Processing pro-Brain Natriuretic Peptide (proBNP) to Amino-Terminal BNP and BNP-32 (1997) (90)
- Left ventricular systolic and diastolic function assessed by tissue Doppler imaging and outcome in asymptomatic aortic stenosis. (2010) (90)
- Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man. (1988) (90)
- Large-Scale Whole-Genome Sequencing of Three Diverse Asian Populations in Singapore (2018) (89)
- Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure. (2014) (87)
- Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction. (2008) (84)
- B-type natriuretic peptides and echocardiographic measures of cardiac structure and function. (2009) (84)
- Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure. (2015) (81)
- Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers. (1992) (81)
- NTproBNP‐guided drug treatment for chronic heart failure: design and methods in the “BATTLESCARRED” trial (2006) (80)
- Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain (2012) (79)
- Regional Release and Clearance of C-Type Natriuretic Peptides in the Human Circulation and Relation to Cardiac Function (2009) (79)
- Serial Doppler echocardiography and tissue Doppler imaging in the detection of elevated directly measured left atrial pressure in ambulant subjects with chronic heart failure. (2011) (78)
- Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct. (2000) (78)
- Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. (2017) (77)
- Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep. (1997) (77)
- Short-term mortality risk in emergency department acute heart failure. (2011) (76)
- B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease. (2005) (74)
- Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. (2005) (74)
- Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. (1994) (73)
- Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension (1993) (73)
- Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis. (2013) (72)
- Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II. (1998) (72)
- The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction (2017) (72)
- Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. (2011) (72)
- Human cerebral arteriovenous vasoactive exchange during alterations in arterial blood gases. (2008) (71)
- The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs. (1999) (70)
- Ouabain is not detectable in human plasma. (1994) (70)
- Diurnal change in plasma atrial natriuretic peptide concentrations. (1987) (70)
- Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. (2003) (70)
- Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. (2007) (69)
- Amino-Terminal proCNP: A Putative Marker of Cartilage Activity in Postnatal Growth (2005) (69)
- Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers (2019) (69)
- Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics. (2009) (69)
- Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses. (2007) (68)
- Asian Sudden Cardiac Death in Heart Failure (ASIAN‐HF) registry (2013) (68)
- Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction. (2008) (68)
- C-terminal pro-ghrelin peptides are present in the human circulation. (2003) (66)
- A Systematic Review and Network-Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction (2021) (66)
- Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population. (2017) (66)
- Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure. (1996) (65)
- Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study). (1994) (64)
- Hemodynamic, Hormone, and Urinary Effects of Adrenomedullin Infusion in Essential Hypertension (2000) (64)
- Treatment of heart failure guided by plasma amino-terminal brain natriuretic peptide (N-BNP) levels improves outcome (2000) (63)
- Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep. (1996) (63)
- Apelin-13 induces a biphasic haemodynamic response and hormonal activation in normal conscious sheep. (2006) (62)
- Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure. (1999) (61)
- Hyponatremia, Natriuretic Peptides, and Outcomes in Acutely Decompensated Heart Failure: Results From the International Collaborative of NT-proBNP Study (2010) (60)
- Characterisation of proghrelin peptides in mammalian tissue and plasma. (2007) (60)
- Betaine and Secondary Events in an Acute Coronary Syndrome Cohort (2012) (60)
- SYNCOPE IN AORTIC VALVULAR STENOSIS (1984) (60)
- Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction (2018) (59)
- Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation. (2003) (59)
- Angiotensinogen M235T and T174M Gene Polymorphisms in Combination Doubles the Risk of Mortality in Heart Failure (2007) (59)
- Differing metabolism and bioactivity of atrial and brain natriuretic peptides in essential hypertension. (1996) (58)
- Structure and belonging: Pathways to success for underrepresented minority and women PhD students in STEM fields (2019) (58)
- Amino-Terminal Pro–C-Type Natriuretic Peptide in Heart Failure (2004) (58)
- Angiotensin Type-1 Receptor A1166C Gene Polymorphism Correlates With Oxidative Stress Levels in Human Heart Failure (2006) (57)
- Regional clearance of amino‐terminal pro‐brain natriuretic peptide from human plasma (2009) (57)
- Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis. (2015) (57)
- ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain. (2012) (57)
- Vasopressin, corticotrophin-releasing factor, and pituitary adrenal responses to acute cold stress in normal humans. (1992) (57)
- OSA and coronary plaque characteristics. (2014) (56)
- ATRIAL AND BRAIN NATRIURETIC PEPTIDE RESPONSE TO EXERCISE IN PATIENTS WITH ISCHAEMIC HEART DISEASE (1993) (56)
- ATRIAL NATRIURETIC PEPTIDE An Important Factor in Sodium and Blood Pressure Regulation (1989) (56)
- Up-regulation of miRNA-221 inhibits hypoxia/reoxygenation-induced autophagy through the DDIT4/mTORC1 and Tp53inp1/p62 pathways. (2016) (56)
- Elevated plasma cholecystokinin at high altitude: metabolic implications for the anorexia of acute mountain sickness. (2000) (56)
- Central C-type natriuretic peptide but not atrial natriuretic factor lowers blood pressure and adrenocortical secretion in normal conscious sheep. (1992) (56)
- Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction. (2004) (54)
- Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition. (1995) (54)
- Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes. (2019) (54)
- Degradation of Human Adrenomedullin(1-52) by Plasma Membrane Enzymes and Identification of Metabolites (1997) (54)
- The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and design. (2013) (54)
- Effect of urocortin 1 infusion in humans with stable congestive cardiac failure. (2005) (54)
- Hyponatremic-hypertensive syndrome with renal ischemia: an underrecognized disorder. (1999) (54)
- Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure (2006) (53)
- Real-World Experience with Insertable Cardiac Monitors to Find Atrial Fibrillation in Cryptogenic Stroke (2015) (53)
- A Common Variant at Chromosome 9P21.3 Is Associated With Age of Onset of Coronary Disease but Not Subsequent Mortality (2010) (53)
- Dendroaspis natriuretic peptide: endogenous or dubious? (2002) (53)
- Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure. (2005) (53)
- Natriuretic Peptides: Update on Peptide Release, Bioactivity, and Clinical Use (2007) (53)
- Resistin worsens cardiac ischaemia-reperfusion injury. (2006) (53)
- Plasma brain natriuretic peptide after long‐term treatment for heart failure in general practice (2002) (53)
- Markers of Cardiac Dysfunction in Cognitive Impairment and Dementia (2015) (52)
- Electrophysiological Effects of atrial Natriuretic Peptide on the Cardiac Conduction System in Man (1993) (52)
- Genomic selection of reference genes for real-time PCR in human myocardium (2008) (52)
- Association of obesity with heart failure outcomes in 11 Asian regions: A cohort study (2019) (52)
- Endopeptidase 24.11 inhibition by SCH 42495 in essential hypertension. (1993) (52)
- The effects of medications on circulating levels of cardiac natriuretic peptides (2007) (52)
- High-sensitivity troponin T for early rule-out of myocardial infarction in recent onset chest pain (2011) (51)
- Urotensin II: Evidence for cardiac, hepatic and renal production (2005) (51)
- A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score. (2006) (51)
- A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU Trial. (2017) (51)
- Plasma atrial natriuretic peptide concentrations during exercise in sodium replete and deplete normal man. (1987) (51)
- Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction (2019) (50)
- Hybrid PET/CT and PET/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction (2018) (50)
- Association Between Subclinical Cardiac Biomarkers and Clinically Manifest Cardiac Diseases With Cortical Cerebral Microinfarcts (2017) (50)
- Plasma Lipids and Betaine Are Related in an Acute Coronary Syndrome Cohort (2011) (50)
- Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure. (2006) (50)
- Validity of a Novel Point-of-Care Troponin Assay for Single-Test Rule-Out of Acute Myocardial Infarction (2018) (49)
- Plasma corticotrophin releasing hormone, vasopressin, ACTH and Cortisol responses to acute myocardial infarction (1994) (49)
- Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta‐analysis (2015) (49)
- Urocortin-2 infusion in acute decompensated heart failure: findings from the UNICORN study (urocortin-2 in the treatment of acute heart failure as an adjunct over conventional therapy). (2013) (48)
- Endogenous urocortins reduce vascular tone and renin-aldosterone/endothelin activity in experimental heart failure. (2005) (48)
- N-Terminal B-type Natriuretic Peptide in Heart Failure. (2018) (48)
- Go beyond bias training (2018) (48)
- Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. (2011) (48)
- Beneficial Renal and Hemodynamic Effects of Omapatrilat in Mild and Severe Heart Failure (2000) (48)
- Cardiovascular actions of ANF: contributions of renal, neurohumoral, and hemodynamic factors in sheep. (1993) (47)
- The Chromosome 9p21.3 Coronary Heart Disease Risk Allele Is Associated with Altered Gene Expression in Normal Heart and Vascular Tissues (2012) (47)
- B-type natriuretic peptide infusions in acute myocardial infarction (2007) (47)
- BNP in hormone-guided treatment of heart failure (2002) (47)
- Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study (2012) (47)
- Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury (2008) (46)
- Genomic Risk Variants at 1p13.3, 1q41, and 3q22.3 Are Associated With Subsequent Cardiovascular Outcomes in Healthy Controls and in Established Coronary Artery Disease (2011) (46)
- The effects of pathophysiological increments in brain natriuretic peptide in left ventricular systolic dysfunction. (1997) (46)
- Combined Endopeptidase Inhibition and Adrenomedullin in Sheep With Experimental Heart Failure (2002) (45)
- Plasma Urocortin 1 in Human Heart Failure (2009) (45)
- Urotensin II in the cardiovascular system (2004) (45)
- A new improved accelerated diagnostic protocol safely identifies low-risk patients with chest pain in the emergency department. (2012) (44)
- The natriuretic peptides in heart failure (2004) (44)
- Natriuretic peptide responses to acute and chronic ventricular pacing in sheep. (1996) (44)
- Low-dose infusion of atrial natriuretic factor in mild essential hypertension. (1989) (43)
- Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients. (1994) (43)
- The ovine hypothalamus and pituitary have markedly different distributions of C-type natriuretic peptide forms (1993) (43)
- Haemodynamic, hormonal and renal effects of adrenocorticotrophic hormone in sodium-restricted man. (1988) (43)
- Assay of endopeptidase-24.11 activity in plasma applied to in vivo studies of endopeptidase inhibitors. (1992) (43)
- Hypotensive and Natriuretic Actions of Adrenomedullin in Subjects With Chronic Renal Impairment (2001) (43)
- Adrenomedullin expression in rat uterus is correlated with plasma estradiol. (2002) (43)
- B-type Natriuretic Peptide circulating forms: Analytical and bioactivity issues. (2015) (42)
- MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease. (2017) (42)
- Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study. (2007) (42)
- Hypertension and heart failure. (1997) (42)
- Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study. (1989) (42)
- B-Type Natriuretic Peptide Signal Peptide Circulates in Human Blood: Evaluation as a Potential Biomarker of Cardiac Ischemia (2010) (42)
- Atrial natriuretic peptides and renin release. (1988) (42)
- Combining High-Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction (2018) (41)
- Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep. (1995) (41)
- Unsatisfactory redefinition of myocardial infarction (2001) (41)
- Heart Failure With Preserved Ejection Fraction in the Young (2017) (41)
- Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction (2019) (41)
- Adrenomedullin and heart failure (2003) (41)
- Circulating miR-323-3p and miR-652: candidate markers for the presence and progression of acute coronary syndromes. (2014) (41)
- Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community. (2008) (40)
- Plasma amino-terminal pro C-type natriuretic Peptide in the neonate: relation to gestational age and postnatal linear growth. (2008) (40)
- ST2 in stable and unstable ischemic heart diseases. (2015) (40)
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. (2021) (40)
- Hemodynamic, renal, and endocrine actions of ANF in sheep: effect of 24-h, low-dose infusions. (1990) (40)
- CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic (2017) (40)
- GYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia. (2015) (40)
- Accelerated diagnostic protocol using high-sensitivity cardiac troponin T in acute chest pain patients. (2015) (40)
- Differences in STEM doctoral publication by ethnicity, gender and academic field at a large public research university (2017) (40)
- Hemodynamic, hormonal, and renal effects of intracerebroventricular adrenomedullin in conscious sheep. (1998) (40)
- Cardiac biomarker responses to dobutamine stress echocardiography in healthy volunteers and patients with coronary artery disease. (2012) (40)
- Genetic Polymorphism rs6922269 in the MTHFD1L Gene Is Associated with Survival and Baseline Active Vitamin B12 Levels in Post-Acute Coronary Syndromes Patients (2014) (40)
- Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction. (2010) (40)
- Impact of age, phenotype and cardio‐renal function on plasma C‐type and B‐type natriuretic peptide forms in an adult population (2013) (39)
- Examining the signs and symptoms experienced by individuals with suspected acute coronary syndrome in the Asia-Pacific region: a prospective observational study. (2012) (39)
- Prognostic implication of obstructive sleep apnea diagnosed by post-discharge sleep study in patients presenting with acute coronary syndrome. (2014) (39)
- A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis. (2008) (39)
- Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension. (1993) (39)
- Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study. (2013) (39)
- Prevalence and Clinical Significance of Diabetes in Asian Versus White Patients With Heart Failure. (2017) (38)
- Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN‐HF Registry (2019) (38)
- Discovery of Potential Therapeutic miRNA Targets in Cardiac Ischemia–Reperfusion Injury (2016) (38)
- N-terminal pro-C-type natriuretic peptide, but not C-type natriuretic peptide, is greatly elevated in the fetal circulation. (2004) (38)
- Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure. (2007) (37)
- Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure. (1997) (37)
- Prolonged Urocortin 2 Administration in Experimental Heart Failure: Sustained Hemodynamic, Endocrine, and Renal Effects (2011) (37)
- Prolonged inhibition of endopeptidase 24.11 in normal man: renal, endocrine and haemodynamic effects. (1991) (37)
- Circadian Dependence of Infarct Size and Acute Heart Failure in ST Elevation Myocardial Infarction (2015) (37)
- Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure. (1986) (37)
- Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man. (1998) (36)
- Adrenomedullin and the renin–angiotensin–aldosterone system (2003) (36)
- Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies. (2015) (36)
- Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. (1995) (36)
- Use of natriuretic peptides to guide and monitor heart failure therapy. (2012) (36)
- A cohort study comparing cardiovascular risk factors in rural Māori, urban Māori and non-Māori communities in New Zealand (2012) (36)
- AMINOPROPYLIDINE DIPHOSPHONATE (APD) IN MILD PRIMARY HYPERPARATHYROIDISM: EFFECT ON CLINICAL STATUS (1990) (35)
- Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs (2019) (35)
- Hemodynamic, hormonal, and renal actions of adrenomedullin-2 in normal conscious sheep. (2006) (35)
- The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides (1996) (35)
- Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure. (2004) (34)
- Plasma clearance and effects of alpha-hANP infused in patients with end-stage renal failure. (1988) (34)
- Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia (2016) (34)
- ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway (2017) (34)
- The flow of mitochondria in chicken sciatic nerve. (1972) (34)
- Endopeptidase-24.11 in human plasma degrades atrial natriuretic factor (ANF) to ANF(99–105/106–126) (1989) (34)
- Comparison of high sensitivity troponin T and I assays in the diagnosis of non-ST elevation acute myocardial infarction in emergency patients with chest pain. (2014) (34)
- Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. (2009) (34)
- An autologous platelet-rich plasma hydrogel compound restores left ventricular structure, function and ameliorates adverse remodeling in a minimally invasive large animal myocardial restoration model: a translational approach: Vu and Pal "Myocardial Repair: PRP, Hydrogel and Supplements". (2015) (33)
- Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure (2017) (33)
- Hormone, calcium and blood pressure relationships in primary hyperparathyroidism. (1988) (33)
- Rapid assay of plasma brain natriuretic peptide in the assessment of acute dyspnoea. (1997) (33)
- Human Mesenchymal Stem Cell-derived Exosomes Reduce Ischemia/Reperfusion Injury by the Inhibitions of Apoptosis and Autophagy. (2019) (33)
- Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injury. (2008) (32)
- Natriuretic peptide receptor 3 (NPR3) is regulated by microRNA-100. (2015) (32)
- Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN‐HF registry (2018) (32)
- Long-Term Adrenomedullin Administration in Experimental Heart Failure (2002) (32)
- Comparison of new point-of-care troponin assay with high sensitivity troponin in diagnosing myocardial infarction. (2014) (32)
- mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection (2014) (32)
- Serial ST2 testing in hospitalized patients with acute heart failure. (2015) (32)
- EXERCISE TESTING IN THE ASSESSMENT OF CHRONIC CONGESTIVE HEART FAILURE (2002) (32)
- Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction. (2000) (32)
- Hyperuricaemia and gout in New Zealand rural and urban Māori and non‐Māori communities (2013) (31)
- Myocardial infarction with and without reperfusion in sheep: early cardiac and neurohumoral changes. (2000) (31)
- Biochemistry of ghrelin precursor peptides. (2008) (31)
- Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002. (2010) (31)
- Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk: An Observational Study. (2018) (31)
- CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects. (2012) (31)
- High plasma thiocyanate levels are associated with enhanced myeloperoxidase-induced thiol oxidation and long-term survival in subjects following a first myocardial infarction (2014) (31)
- Ankyrin Repeat Domain 1 Protein: A Functionally Pleiotropic Protein with Cardiac Biomarker Potential (2017) (31)
- Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort (2016) (31)
- MicroRNA-221 Is Cardioprotective and Anti-fibrotic in a Rat Model of Myocardial Infarction (2019) (31)
- Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action. (2018) (31)
- Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine. (2018) (30)
- Superior performance of N‐terminal pro brain natriuretic peptide for diagnosis of acute decompensated heart failure in an Asian compared with a Western setting (2017) (30)
- Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC) (2021) (30)
- Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department (2018) (30)
- A 2-hour thrombolysis in myocardial infarction score outperforms other risk stratification tools in patients presenting with possible acute coronary syndromes: comparison of chest pain risk stratification tools. (2012) (30)
- Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection (2014) (30)
- Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment. (1999) (29)
- Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension (2007) (29)
- Computational Fluid Dynamics Modelling of Hemodynamic Parameters in the Human Diseased Aorta - A Systematic Review. (2020) (29)
- Coenzyme Q 10 (2008) (29)
- Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris. (1990) (29)
- A Kaupapa Māori approach to a community cohort study of heart disease in New Zealand (2011) (28)
- A porcine model of heart failure with preserved ejection fraction: magnetic resonance imaging and metabolic energetics (2019) (28)
- Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in man (2001) (28)
- Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction. (2010) (28)
- Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure. (2008) (28)
- Regional sampling and the effects of experimental heart failure in sheep: Differential responses in A, B and C-type natriuretic peptides (2006) (28)
- First identification of circulating prepro-A-type natriuretic peptide (preproANP) signal peptide fragments in humans: initial assessment as cardiovascular biomarkers. (2012) (28)
- Systemic Mesenchymal Stem Cell-Derived Exosomes Reduce Myocardial Infarct Size: Characterization With MRI in a Porcine Model (2020) (28)
- Endogenous ouabain, sodium balance and blood pressure. (1996) (27)
- Atrial Natriuretic Factor in Hypertension: Bioactivity at Normal Plasma Levels (1989) (27)
- Ethnicity Modifies Associations between Cardiovascular Risk Factors and Disease Severity in Parallel Dutch and Singapore Coronary Cohorts (2015) (27)
- The role of adrenomedullin. (1999) (27)
- Coenzyme Q 10 An Independent Predictor of Mortality in Chronic Heart Failure (2008) (27)
- Blockade of the renin-angiotensin system. (1994) (27)
- Validating aminoterminal BNP assays: a word of caution (1999) (26)
- Management of raised blood pressure in New Zealand. (1993) (26)
- Comparative actions of adrenomedullin and nitroprusside: interactions with ANG II and norepinephrine. (2001) (26)
- Single‐dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo‐controlled study (PRACTICE‐ASIA‐HF) (2018) (26)
- Soluble neprilysin retains catalytic activity in heart failure. (2016) (26)
- The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin (2018) (26)
- Natriuretic peptides in heart failure with preserved ejection fraction. (2014) (26)
- Multinational and multiethnic variations in health‐related quality of life in patients with chronic heart failure (2017) (25)
- Comparative bioactivity of atrial and brain natriuretic peptides in an ovine model of heart failure. (1997) (25)
- Brain natriuretic peptide-guided therapy for heart failure (2001) (25)
- Characteristics of Aortic Wall Extracellular Matrix in Patients with Acute Myocardial Infarction: Tissue Microarray Detection of Collagen I, Collagen III and Elastin Levels (2012) (25)
- Urocortins: putative role in cardiovascular disease. (2004) (25)
- Agents with vasodilator properties in acute heart failure: how to design successful trials (2015) (25)
- Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. (2008) (25)
- Ambulatory pulmonary arterial pressure in primary pulmonary hypertension: variability, relation to systemic arterial pressure, and plasma catecholamines. (1990) (25)
- Atrial natriuretic factor reduces vasopressin and angiotensin II but not the ACTH response to acute hypoglycaemic stress in normal men (1993) (25)
- Urocortin 2 Inhibits Furosemide-Induced Activation of Renin and Enhances Renal Function and Diuretic Responsiveness in Experimental Heart Failure (2009) (25)
- Central and peripheral forms of C-type natriuretic peptide (CNP): Evidence for differential regulation in plasma and cerebrospinal fluid (2011) (25)
- Distinctive molecular signature and activated signaling pathways in aortic smooth muscle cells of patients with myocardial infarction. (2018) (25)
- Future biomarkers in cardiology: my favourites (2018) (24)
- Cardiovascular effects of native and non-native urotensin II and urotensin II-related peptide on rat and salmon hearts (2006) (24)
- Adrenomedullin in heart failure. (2003) (24)
- Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs. (2007) (24)
- Coenzyme Q10; an adjunctive therapy for congestive heart failure? (2009) (24)
- Excessive daytime sleepiness is associated with longer culprit lesion and adverse outcomes in patients with coronary artery disease. (2013) (24)
- Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse. (2013) (24)
- Acute effects of intravenous ouabain in healthy volunteers. (1994) (24)
- Continuous positive airway pressure in heart failure patients with obstructive sleep apnoea (2008) (24)
- Genetic variation in the renin–angiotensin–aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease (2013) (23)
- Prioritizing Candidates of Post–Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics (2020) (23)
- EC 24.11 inhibition in man alters clearance of atrial natriuretic peptide. (1991) (23)
- C-Type Natriuretic Peptides in Coronary Disease. (2017) (23)
- An Ovine Model of Acute Myocardial Infarction and Chronic Left Ventricular Dysfunction (1997) (23)
- Impact of Selection Bias on Estimation of Subsequent Event Risk (2017) (23)
- Plasma extracellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease (2013) (23)
- Plasma urocortin 1 in sheep: Regional sampling and effects of experimental heart failure (2006) (23)
- ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased With Obesity in Patients with Heart Failure. (2019) (23)
- The natriuretic peptides and hypertension (1994) (23)
- Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failure. (2010) (23)
- Interaction of angiotensin converting enzyme inhibition and atrial natriuretic factor. (1989) (22)
- Long-term survival and residual hazard after in-hospital cardiac arrest. (2006) (22)
- N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure (2016) (22)
- Adrenomedullin attenuates pressor response to angiotensin II in conscious sheep. (2000) (22)
- The Interaction between 30b-5p miRNA and MBNL1 mRNA is Involved in Vascular Smooth Muscle Cell Differentiation in Patients with Coronary Atherosclerosis (2019) (22)
- Urocortin 2 induces potent long-lasting inhibition of cardiac sympathetic drive despite baroreflex activation in conscious sheep. (2010) (22)
- Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine. (1994) (22)
- Prevalence and Clinical Significance of Diabetes in Asian Versus White Patients With Heart Failure. (2016) (22)
- Heart Fatty Acid Binding Protein and cardiac troponin: development of an optimal rule-out strategy for acute myocardial infarction (2016) (22)
- Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in a conscious sheep model. (2007) (22)
- Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study. (2021) (22)
- Acute Inhibition of Endopeptidase 24.11 in Essential Hypertension: SCH 34826 Enhances Atrial Natriuretic Peptide and Natriuresis Without Lowering Blood Pressure (1992) (21)
- Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events (2019) (21)
- Does renal clearance differ between the B-type natriuretic peptides (BNP versus NT-proBNP)? (2009) (21)
- Epicardial fat in heart failure with reduced versus preserved ejection fraction (2021) (21)
- Risk Stratification Model for 30-Day Heart Failure Readmission in a Multiethnic South East Asian Community. (2017) (20)
- Characteristics of aortic wall extracellular matrix in patients with acute myocardial infarction: tissue microarray detection of collagen I, collagen III and elastin levels. (2013) (20)
- Fibrates may Cause an Abnormal Urinary Betaine Loss Which is Associated with Elevations in Plasma Homocysteine (2009) (20)
- Hemodynamic, Hormonal, and Renal Effects of (Pro)Renin Receptor Blockade in Experimental Heart Failure (2012) (20)
- Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure. (2002) (20)
- Plasma amino-terminal B-type natriuretic peptide measured by Elecsys 2010 assay in a trial of hormone-guided treatment for heart failure. (2003) (20)
- Survival After Rate-Responsive Programming in Patients With Cardiac Resynchronization Therapy-Defibrillator Implants Is Associated With a Novel Parameter: The Heart Rate Score (2016) (20)
- Ile164 variant of β2‐adrenoceptor does not influence outcome in heart failure but may interact with β blocker treatment (2008) (20)
- Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals. (2019) (20)
- Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease. (2004) (20)
- Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T (2020) (20)
- NT-Pro BNP Secretion and Clinical Endpoints in Cardiac Surgery Intensive Care Patients (2007) (20)
- Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT‐CHF and ASIAN‐HF registries (2020) (20)
- The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction (2009) (20)
- What we know about cardiomyocyte dedifferentiation. (2020) (20)
- Differences in late cardiovascular mortality following acute myocardial infarction in three major Asian ethnic groups (2014) (20)
- Natriuretic peptides in sheep with pressure overload left ventricular hypertrophy. (1996) (19)
- Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry (2021) (19)
- Heart attacks and unstable angina (acute coronary syndromes) have doubled in New Zealand since 1989: how do we best manage the epidemic? (2005) (19)
- Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction. (2009) (19)
- Identification of novel microRNAs in the sheep heart and their regulation in heart failure (2017) (19)
- Ile164 variant of beta2-adrenoceptor does not influence outcome in heart failure but may interact with beta blocker treatment. (2008) (19)
- Amino-terminal pro-B-type natriuretic peptide testing in patients with diabetes mellitus and with systemic hypertension. (2008) (19)
- Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta‐Analysis of Randomized Controlled Trials (2017) (19)
- Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study (2018) (19)
- Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort Study (2019) (19)
- Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients. (2006) (18)
- Multimarker testing with ST2 in chronic heart failure. (2015) (18)
- Development of a BNP1-32 Immunoassay That Does Not Cross-React with proBNP. (2017) (18)
- Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific (2019) (18)
- Effect of sex steroids on plasma C-type natriuretic peptide forms: stimulation by oestradiol in lambs and adult sheep. (2008) (18)
- Drug-induced hypertension. (1991) (18)
- CHRISTCHURCH CARDIOENDO-CRINE RESEARCH GROUP; AUSTRALIA-NEW ZEALAND HEART FAILURE GROUP. COMPARISON OF BT-YPE NATRIURETIC PEPTIDES FOR ASSESSMENT OF CARDIAC FUNCTION AND PROGNOSIS IN STABLE ISCHEMIC HEART DISEASE (2006) (18)
- Skeletal contributions to plasma CNP forms: Evidence from regional sampling in growing lambs (2009) (18)
- Unravelling the proteome of degenerative human mitral valves (2015) (18)
- ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients. (2010) (18)
- Pharmacodynamic responses of plasma and tissue C-type natriuretic peptide to GH: correlation with linear growth in GH-deficient rats. (2012) (18)
- Urocortins: Actions in health and heart failure. (2017) (18)
- Cardiac function and lipid distribution in rats fed a high-fat diet: in vivo magnetic resonance imaging and spectroscopy. (2013) (18)
- Low-dose brain natriuretic peptide infusion in normal men and the influence of endopeptidase inhibition. (1997) (18)
- High-Sensitivity Sandwich ELISA for Plasma NT-proUcn2: Plasma Concentrations and Relationship to Mortality in Heart Failure. (2016) (18)
- Plasma atrial natriuretic peptide: responses to modest and severe sodium restriction. (1986) (18)
- Generation and characterization of a mouse model of the metabolic syndrome: apolipoprotein E and aromatase double knockout mice. (2012) (18)
- Early kinetic profiles of troponin I and T measured by high-sensitivity assays in patients with myocardial infarction. (2020) (18)
- Characterization and Standardization of Cultured Cardiac Fibroblasts for Ex Vivo Models of Heart Fibrosis and Heart Ischemia. (2017) (18)
- What we may expect from biomarkers in heart failure. (2009) (18)
- Ovine atrial natriuretic factor: Sequence of circulating forms and metabolism in plasma (1991) (18)
- MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction. (2018) (18)
- Urocortin 2 sustains haemodynamic and renal function during introduction of beta-blockade in experimental heart failure (2011) (18)
- Clinical applications of B-type natriuretic peptides (2004) (17)
- Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement. (2008) (17)
- Images in cardiovascular medicine. Dynamic myocardial ischemia caused by circumflex artery stenosis detected by a new implantable left atrial pressure monitoring device. (2006) (17)
- Ouabain: a new steroid hormone? (1995) (17)
- Cardiac natriuretic peptides as predictors of mortality (1997) (17)
- Long-term prognosis and risk heterogeneity of heart failure complicating acute myocardial infarction. (2015) (17)
- New Zealand priority criteria project (1997) (17)
- New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis (2010) (17)
- Hemodynamic, Hormonal, and Renal Actions of Phosphodiesterase-9 Inhibition in Experimental Heart Failure. (2019) (17)
- Urocortin 1 exhibits potent inhibition of cardiac sympathetic nerve activity in conscious sheep (2008) (17)
- Effectiveness of advanced practice nurse-led telehealth on readmissions and health-related outcomes among patients with post-acute myocardial infarction: ALTRA Study Protocol. (2016) (17)
- Central angiotensin II AT1-receptor antagonism in normal and heart-failed sheep. (1995) (17)
- Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure. (1997) (16)
- Regional vascular response to ProAngiotensin-12 (PA12) through the rat arterial system (2010) (16)
- Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology (2021) (16)
- An International Consensus Statement Regarding Amino-Terminal Pro-B- Type Natriuretic Peptide Testing: The International NT-proBNP Consensus Panel (2008) (16)
- Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in a conscious sheep model (2007) (16)
- Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter‐defibrillator systems: Results of the SENSE trial (2019) (16)
- Continuous recording of pulmonary artery pressure in unrestricted subjects. (1984) (16)
- Outcomes in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome with Elevated Cardiac Troponin but Non-obstructive Coronary Disease on Angiography. (2015) (16)
- Degenerative protein modifications in the aging vasculature and central nervous system: A problem shared is not always halved (2019) (16)
- Differing thresholds for modulatory effects of adrenomedullin infusion on haemodynamic and hormone responses to angiotensin II and adrenocorticotrophic hormone in healthy volunteers. (2001) (16)
- Mineralocorticoid receptor antagonists for heart failure (2011) (16)
- Central C-type natriuretic peptide augments the hormone response to hemorrhage in conscious sheep (1995) (16)
- Characterization of NT-proBNP in human urine. (2009) (16)
- Complications of Intra-Aortic Balloon Pump Use: Does the Final Position of the IABP Tip Matter? (2015) (16)
- Chronic ouabain infusion does not cause hypertension in sheep. (1996) (15)
- Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure (2016) (15)
- ATRIAL NATRIURETIC FACTOR IN HUMAN PATHOPHYSIOLOGY (1988) (15)
- NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories. (2021) (15)
- Gene expression profile analysis of aortic vascular smooth muscle cells reveals upregulation of cadherin genes in myocardial infarction patients. (2018) (15)
- Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients (2015) (15)
- Flow dynamics and energy efficiency of flow in the left ventricle during myocardial infarction (2017) (15)
- (Pro)renin Receptor Blockade Ameliorates Cardiac Injury and Remodeling and Improves Function After Myocardial Infarction. (2016) (15)
- Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease. (2006) (15)
- Community screening for cardiovascular risk factors and levels of treatment in a rural Māori cohort (2011) (15)
- Urotensin II immunoreactivity in the human circulation: evidence for widespread tissue release. (2009) (15)
- The incremental value of stress testing in patients with acute chest pain beyond serial cardiac troponin testing (2015) (15)
- Nuevos biomarcadores en la insuficiencia cardiaca: aplicaciones en el diagnóstico, pronóstico y pautas de tratamiento (2010) (15)
- Plasma Atrial Natriuretic Peptide in Stable and Accelerated Essential Hypertension (1986) (15)
- Differential MicroRNA Expression Profile in Myxomatous Mitral Valve Prolapse and Fibroelastic Deficiency Valves (2016) (15)
- Guiding and monitoring of heart failure therapy with NT-ProBNP: concepts and clinical studies. (2005) (15)
- Prevalence, clinical correlates, and outcomes of anaemia in multi‐ethnic Asian patients with heart failure with reduced ejection fraction (2018) (15)
- Removal of Contrast Media from the Coronary Sinus Attenuates Renal Injury After Coronary Angiography and Intervention (2010) (14)
- Contrasting plasma atrial natriuretic factor concentrations during comparable natriuresis with infusions of atrial natriuretic factor and saline in normal man. (1988) (14)
- Hydrogen Sulfide Treatment Improves Post-Infarct Remodeling and Long-Term Cardiac Function in CSE Knockout and Wild-Type Mice (2020) (14)
- Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype (2021) (14)
- Subsequent Event Risk in Individuals With Established Coronary Heart Disease (2019) (14)
- Validation of the Vancouver Chest Pain Rule using troponin as the only biomarker: a prospective cohort study. (2013) (14)
- Atrial natriuretic peptide in human hypertension. (1987) (14)
- Intracerebroventricular atrial natriuretic factor (ANF) antiserum inhibits volume-induced ANF in sheep: evidence for the brain's regulation of ANF secretion. (1991) (14)
- Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and intervention. (2010) (14)
- Ambulatory pulmonary arterial pressures in humans: relationship to arterial pressure and hormones. (1986) (14)
- Examining renal impairment as a risk factor for acute coronary syndrome: a prospective observational study. (2013) (14)
- BNP for clinical monitoring of heart failure. (2006) (13)
- Plasma corin levels provide minimal prognostic utility incremental to natriuretic peptides in chronic systolic heart failure. (2010) (13)
- The ethnicity-specific association of biomarkers with the angiographic severity of coronary artery disease (2016) (13)
- MicroRNA Let-7d-3p Contributes to Cardiac Protection via Targeting HMGA2 (2019) (13)
- Amino-terminal pro-C-type natriuretic peptide in heart failure. (2003) (13)
- KCNE5 Polymorphism rs697829 is Associated with QT Interval and Survival in Acute Coronary Syndromes Patients (2012) (13)
- microRNA-221 Inhibits Latent TGF-β1 Activation through Targeting Thrombospondin-1 to Attenuate Kidney Failure-Induced Cardiac Fibrosis (2020) (13)
- A Risk Assessment Score and Initial High‐sensitivity Troponin Combine to Identify Low Risk of Acute Myocardial Infarction in the Emergency Department (2018) (13)
- CYP1A1 MSPI (T6235C) gene polymorphism is associated with mortality in acute coronary syndrome patients (2010) (13)
- The utility of presentation and 4-hour high sensitivity troponin I to rule-out acute myocardial infarction in the emergency department. (2015) (13)
- Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes (2018) (13)
- Comparison of infarct-derived and control ovine cardiac myofibroblasts in culture: response to cytokines and natriuretic peptide receptor expression profiles. (2006) (13)
- Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (13)
- C-type natriuretic peptide (CNP) signal peptide fragments are present in the human circulation. (2014) (13)
- A clinical and biochemical score for mortality prediction in patients with acute dyspnoea: derivation, validation and incorporation into a bedside programme (2007) (13)
- MicroRNA-143 modulates the expression of Natriuretic Peptide Receptor 3 in cardiac cells (2018) (12)
- Association of Age, Sex, Body Size and Ethnicity with Electrocardiographic Values in Community-based Older Asian Adults. (2016) (12)
- Racial Differences in Electrocardiographic Characteristics and Prognostic Significance in Whites Versus Asians (2016) (12)
- Urocortin 2 protects heart and kidney structure and function in an ovine model of acute decompensated heart failure: Comparison with dobutamine. (2015) (12)
- Heart failure with preserved ejection fraction diagnostic scores in an Asian population (2020) (12)
- Chronic Urocortin 2 Administration Improves Cardiac Function and Ameliorates Cardiac Remodeling After Experimental Myocardial Infarction (2015) (12)
- Hypothalamo-pituitary-adrenal axis response to coronary artery embolization: an ovine model of acute myocardial infarction. (1997) (12)
- Mid‐regional pro‐adrenomedullin outperforms N‐terminal pro‐B‐type natriuretic peptide for the diagnosis of acute heart failure in the presence of atrial fibrillation (2019) (12)
- C-Type Natriuretic Peptide Expression in Olfactory Regions of Rat Brain Is Modulated by Acute Water Deprivation, Salt Loading and Central Angiotensin II (2001) (12)
- N-terminal-pro-B-type natriuretic peptide: universal marker of cardiovascular risk? (2005) (12)
- Quantification of a Cardiac Biomarker in Human Serum Using Extraordinary Optical Transmission (EOT) (2015) (12)
- A deep learning pipeline for automatic analysis of multi-scan cardiovascular magnetic resonance (2021) (12)
- Human studies with atrial natriuretic factor. (1987) (12)
- Transcriptome alterations of vascular smooth muscle cells in aortic wall of myocardial infarction patients (2018) (12)
- C‐Type natriuretic peptide forms in adult hyperthyroidism: correlation with thyroid hormones and markers of bone turnover (2012) (12)
- Failure of acute intravascular volume expansion to alter plasma vasopressin in the nonhuman primate, Macaca fascicularis. (1980) (12)
- Heart fatty acid binding protein and myoglobin do not improve early rule out of acute myocardial infarction when highly sensitive troponin assays are used. (2012) (12)
- Hypertension in hypothyroidism: arterial pressure and hormone relationships. (1985) (11)
- The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure. (1994) (11)
- The Relationship of Plasma NT-proBNP to Age and Outcomes in Heart Failure. (2016) (11)
- Hemodynamic and Hormonal Effects of Neutral Endopeptidase Inhibitor SCH 39370 in Sheep (1991) (11)
- Hemodynamic, Hormonal, and Renal Actions of Adrenomedullin 2 in Experimental Heart Failure (2008) (11)
- A Device Histogram‐Based Simple Predictor of Mortality Risk in ICD and CRT‐D Patients: The Heart Rate Score (2017) (11)
- Analytical and biological assessment of circulating human erythroferrone. (2020) (11)
- New biomarkers in heart failure: applications in diagnosis, prognosis and guidance of therapy. (2010) (11)
- Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology (2022) (11)
- A His6-SUMO-eXact tag for producing human prepro-urocortin 2 in Escherichia coli for raising monoclonal antibodies. (2014) (11)
- Association of Genetic Variation in the Natriuretic Peptide System with Cardiovascular Outcomes (2010) (11)
- Heart failure: a problem of our age. (2011) (11)
- Metabolic and Blood Pressure Effects of Walnut Supplementation in a Mouse Model of the Metabolic Syndrome (2017) (11)
- Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study (2022) (11)
- Interactions of Enhanced Urocortin 2 and Mineralocorticoid Receptor Antagonism in Experimental Heart Failure (2013) (11)
- Adrenomedullin modulates the neurohumoral response to acute volume loading in normal conscious sheep. (2002) (10)
- Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction (2017) (10)
- Variability in Microplate Surface Properties and Its Impact on ELISA. (2018) (10)
- CNP Signal Peptide in Patients with Cardiovascular Disease (2015) (10)
- Variability of NT-proBNP levels in heart failure: implications for clinical application (2007) (10)
- Health Gains by Using Natriuretic Peptides in Diagnosis, Prognosis and Treatment (2005) (10)
- Exponential increase in clinical use of plasma brain natriuretic peptide (BNP) assays. (2004) (10)
- Haemodynamic, endocrine and renal actions of adrenomedullin 5 in an ovine model of heart failure (2011) (10)
- Can heart failure cause cancer? (2018) (10)
- Venom natriuretic peptides guide the design of heart failure therapeutics. (2020) (10)
- Competitive peptide antagonists of ANF-induced cyclic guanosine monophosphate production. (1989) (10)
- An Independent Predictor of Mortality in Chronic Heart Failure (2008) (10)
- First Medical Contact-to-Device Time and Heart Failure Outcomes Among Patients Undergoing Primary Percutaneous Coronary Intervention (2018) (10)
- Urocortin 3 Inhibits Cardiac Sympathetic Nerve Activity in Conscious Sheep (2011) (10)
- Spectroscopic properties of a novel fluorescent complex of aluminium and quinizarin (1987) (10)
- Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA. (2013) (10)
- Cognitive impairment in Asian patients with heart failure: prevalence, biomarkers, clinical correlates, and outcomes (2019) (10)
- Genetic markers of repolarization and arrhythmic events after acute coronary syndromes. (2015) (10)
- Sleep Apnea Evolution and Left Ventricular Recovery After Percutaneous Coronary Intervention for Myocardial Infarction. (2018) (10)
- Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (10)
- Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure. (1996) (10)
- Monitoring of heart failure: comparison of left atrial pressure with intrathoracic impedance and natriuretic peptide measurements in an experimental model of ovine heart failure (2010) (10)
- Hyponatraemic-hypertensive syndrome due to unilateral renal ischaemia in women who smoke heavily. (1985) (10)
- Endopeptidase inhibition in angiotensin-induced hypertension. Effect of SCH 39370 in sheep. (1995) (9)
- Convalescent troponin and cardiovascular death following acute coronary syndrome (2019) (9)
- Sleep apnoea and cardiovascular outcomes after coronary artery bypass grafting (2020) (9)
- Serial measurements of plasma B-type natriuretic peptides: what do they tell us? (2008) (9)
- Biological Actions of Cleaved Atrial Natriuretic Factor (ANF101–105/106–126) in Conscious Sheep (1991) (9)
- The association of heart failure-related microRNAs with neurohormonal signaling. (2017) (9)
- Electrocardiographic Criteria for Left Ventricular Hypertrophy in Asians Differs from Criteria Derived from Western Populations--Community-based Data from an Asian Population. (2015) (9)
- HEART score performance in Asian and Caucasian patients presenting to the emergency department with suspected acute coronary syndrome (2018) (9)
- Relationship between soluble transferrin receptor and clinical outcomes in patients with Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study. (2022) (9)
- Human plasma atrial natriuretic peptide concentrations in health and disease (1987) (9)
- Rural Transition: KNOW NO BOUNDS (2004) (9)
- Thymosin Beta‐4 Is Elevated in Women With Heart Failure With Preserved Ejection Fraction (2017) (9)
- Abstract 5946: Ntprobnp Guided Treatment for Chronic Heart Failure: Results from the Battlescarred Trial (2008) (9)
- Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization (2020) (9)
- Low miR‐19b‐1‐5p Expression Is Related to Aspirin Resistance and Major Adverse Cardio‐ Cerebrovascular Events in Patients With Acute Coronary Syndrome (2021) (8)
- Extracellular vesicle Cystatin C and CD14 are associated with both renal dysfunction and heart failure (2020) (8)
- Chronic infusions of brain natriuretic peptide in conscious sheep: bioactivity at low physiological levels. (1998) (8)
- Adrenomedullin increases cardiac sympathetic nerve activity in normal conscious sheep. (2005) (8)
- Absence of a NPR-A gene functional deletion allele in a postmyocardial infarction cohort from New Zealand. (2004) (8)
- Echocardiographic Global Longitudinal Strain Is Associated With Myocardial Fibrosis and Predicts Outcomes in Aortic Stenosis (2021) (8)
- B-type natriuretic peptide forms within the heart, coronary sinus, and peripheral circulation in humans: evidence for degradation before secretion. (2014) (8)
- Effect of nutrition on plasma C-type natriuretic peptide forms in adult sheep: evidence for enhanced C-type natriuretic peptide degradation during caloric restriction. (2010) (8)
- Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study. (2018) (8)
- Cardiac natriuretic peptides in heart failure. (1993) (8)
- Association of Factor V Leiden With Subsequent Atherothrombotic Events (2020) (8)
- Reference Values and Release Kinetics of B-Type Natriuretic Peptide Signal Peptide in Patients with Acute Myocardial Infarction. (2015) (8)
- Natriuretic peptides maintain sodium homoeostasis during chronic volume loading post-myocardial infarction in sheep. (2003) (8)
- Cardiac hormones: diagnostic and therapeutic potential. (1997) (8)
- ST2 and Prognosis in Chronic Heart Failure. (2018) (8)
- Plasma B‐type natriuretic peptide levels in cardiac donors (2009) (8)
- Role of ACE inhibitors in hypertension with left ventricular hypertrophy. (1994) (8)
- Individualized treatment of heart failure (2001) (8)
- The influence of timing of polysomnography on diagnosis of obstructive sleep apnea in patients presenting with acute myocardial infarction and stable coronary artery disease. (2013) (8)
- Microengineering in cardiovascular research: new developments and translational applications (2015) (8)
- A single-center experience of transitioning from a routine transfemoral to a transradial intervention approach in ST-elevation myocardial infarction: Impact on door-to-balloon time and clinical outcomes. (2013) (8)
- Longitudinal Community-Based Study of QT Interval and Mortality in Southeast Asians (2016) (8)
- Nabumetone, a new non-steroidal anti-inflammatory drug: a comparison with naproxen. (1983) (7)
- Disease monitoring of patients with chronic heart failure. (2007) (7)
- Arginine vasopressin V1-receptor antagonism in an ovine model of acute myocardial infarction. (1998) (7)
- Building a Longitudinal National Integrated Cardiovascular Database ― Lessons Learnt From SingCLOUD ― (2019) (7)
- Effect of low dose infusions of ile-atrial natriuretic peptide in healthy elderly males: evidence for a postreceptor defect. (1993) (7)
- Large Animal Models of Heart Failure: Reduced vs. Preserved Ejection Fraction (2020) (7)
- Plasma Alpha Human Atrial Natriuretic Peptide (ANP) Response to an Acute Intravenous Saline Load (1986) (7)
- Is Atrial Natriuretic Factor a Physiological Regulator of Sodium Excretion? A Review of the Evidence (1990) (7)
- Patient‐reported outcomes in heart failure with preserved vs. reduced ejection fraction: focus on physical independence (2020) (7)
- Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fraction (2022) (7)
- Physiological role of atrial natriuretic peptide. (1989) (7)
- Ethnic differences in clinical outcome of patients presenting to the emergency department with chest pain (2016) (7)
- N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Biomarker of Cardiac Disease (2005) (7)
- Spectroscopic, photochemical and photoconductive properties of a novel fluorescent polymeric complex of quinizarin and aluminium (1990) (7)
- Socioeconomic Status and Outcomes in Heart Failure With Reduced Ejection Fraction From Asia (2021) (7)
- Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4 (2020) (7)
- Outpatient Management of Heart Failure (2003) (7)
- Circulating Biomarkers of Cardiac Fibrosis: Do We Have Any and What Use Are They? (2017) (7)
- Is hypertension a leading cause of heart failure in Chinese? (2002) (6)
- Prognostic Implications of Dual Platelet Reactivity Testing in Acute Coronary Syndrome (2018) (6)
- Prescription patterns of anti‐diabetic medications and clinical outcomes in Asian patients with heart failure and diabetes mellitus (2019) (6)
- Higher prevalence of left ventricular hypertrophy in two Māori cohorts: findings from the Hauora Manawa/Community Heart Study (2015) (6)
- Endogenous angiotensin-aldosterone-pressure relationships during sodium restriction. (1985) (6)
- Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure. (2020) (6)
- Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injury (2017) (6)
- Remote Postdischarge Treatment of Patients With Acute Myocardial Infarction by Allied Health Care Practitioners vs Standard Care (2020) (6)
- N‐terminal pro‐B‐type natriuretic peptide and prognosis in Caucasian vs. Asian patients with heart failure (2018) (6)
- Renal function and anaemia in acute myocardial infarction. (2013) (6)
- Vasopeptidase inhibitors for heart failure: where do we go from here? (2003) (6)
- Cornell product is an ECG marker of heart failure with preserved ejection fraction (2019) (6)
- Effect of ouabain on pressor responsiveness in normal man. (1994) (6)
- The management of mildly raised blood pressure in New Zealand: an alternative view. (1996) (6)
- Relationship between apnoea-hypopnoea index and angiographic coronary disease phenotypes in patients presenting with acute myocardial infarction (2013) (6)
- Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score (2017) (6)
- Management of raised blood pressure. (1994) (6)
- A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012. (2017) (5)
- Obstructive sleep apnea is associated with visit-to-visit variability in low-density lipoprotein-cholesterol in patients with coronary artery disease (2017) (5)
- Natriuretic peptide analogues with distinct vasodilatory or renal activity: Integrated effects in health and experimental heart failure. (2020) (5)
- Atrial natriuretic factor and changes in the aldosterone response to angiotensin II in sodium depleted dogs. (1993) (5)
- Pro-Inflammatory Derangement of the Immuno-Interactome in Heart Failure (2022) (5)
- A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation (2018) (5)
- Plasma amino-terminal pro-B-type natriuretic peptide predicts postcardioversion reversion to atrial fibrillation (2003) (5)
- Determination of the severity of underlying lesions in acute myocardial infarction on the basis of collateral vessel development (2014) (5)
- Aldosterone antagonism in heart failure (1999) (5)
- Screening of hospitalized patients at high risk of obstructive sleep apnea in general cardiology service. (2013) (5)
- Addition of minute ventilation to rate-response pacing improves heart rate score more than accelerometer alone. (2018) (5)
- Biomarkers in Acute Heart Failure - Cardiac And Kidney. (2015) (5)
- Blood pressure and vasoactive hormones with improved glycaemic control in patients with diabetes mellitus. (1989) (5)
- Inefficacy of daily single bolus dose atrial natriuretic factor in chronic congestive heart failure. (1989) (5)
- B-type natriuretic peptide signal peptide (BNPsp) in patients presenting with chest pain. (2016) (5)
- Angiotensin II type-I receptor antagonists in the treatment of heart failure. (1997) (5)
- Immigrant status and disparities in health care delivery in patients with myocardial infarction. (2013) (5)
- Arterial pressure and hormone relationships in phaeochromocytoma. (1983) (5)
- Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events (2021) (5)
- Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure (2022) (5)
- NITRIC OXIDE INHIBITION IN AN OVINE MODEL OF HEART FAILURE (1996) (5)
- Adrenomedullin in hypertension (2000) (5)
- Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome (2019) (5)
- Human muscle sympathetic nerve responses to urocortin‐2 in health and stable heart failure (2015) (4)
- Plasma Neprilysin Concentrations: A New Prognostic Marker in Heart Failure? (2015) (4)
- Adiponectin Profile in Asian Patients Undergoing Coronary Revascularization and Its Association With Plaque Vulnerability: IDEAS‐ADIPO Study (2012) (4)
- Concentraciones plasmáticas de neprilisina: ¿un nuevo marcador pronóstico en la insuficiencia cardiaca? (2015) (4)
- Comparison of platinum chromium everolimus-eluting stent with cobalt chromium everolimus-eluting stent in unselected patients undergoing percutaneous coronary intervention. (2015) (4)
- Fibrinogen and hemoglobin predict near future cardiovascular events in asymptomatic individuals (2021) (4)
- Cardiac failure, the kidney, renin and atrial peptides. (1988) (4)
- ProBNP processing is decreased by obesity in patients with heart failure. (2020) (4)
- Myocardial infarction in singapore: ethnic variation in evidence-based therapy and its association with socioeconomic status, social network size and perceived stress level. (2013) (4)
- Association between body surface area and prescribed doses of guideline‐directed medications among international patients with heart failure and reduced ejection fraction (2019) (4)
- Variability of the Plasma Lipidome and Subclinical Coronary Atherosclerosis (2021) (4)
- Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors (2021) (4)
- COMPARISON OF THE EFFECTS OF OUABAIN AND BRAIN NATRIURETIC PEPTIDE IN SALINE‐LOADED SHEEP (1997) (4)
- Precordial electrocardiographic mapping in the identification of patients with left main stem narrowing. (1983) (4)
- Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis (2022) (4)
- Adrenomedullin: correction. (1996) (4)
- Atrial natriuretic factor administered to humans: 1984-1988. (1989) (4)
- Identifying Candidate Circulating RNA Markers for Coronary Artery Disease by Deep RNA-Sequencing in Human Plasma (2022) (4)
- Natriuretic peptides are elevated in aortic regurgitation but correlate poorly with disease severity (2003) (4)
- Acute Decompensated Heart Failure and the Kidney: Physiological, Histological and Transcriptomic Responses to Development and Recovery (2021) (4)
- Ethnic differences in atrial fibrillation among patients with heart failure in Asia (2020) (4)
- The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea (2012) (4)
- Differential response of C-type natriuretic peptide to estrogen and dexamethasone in adult bone (2014) (4)
- Electrocardiographic and Echocardiographic Insights From a Prospective Registry of Asian Elite Athletes (2022) (4)
- Elevated atrial natriuretic factor in the plasma: cause or effect in "idiopathic orthostatic hypotension"? (1990) (4)
- Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation (2021) (4)
- Ethnic differences in quality of life and its association with survival in patients with heart failure (2020) (4)
- Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation. (2015) (4)
- Atrial natriuretic peptides (1986) (4)
- Endotrophin, a Collagen VI Formation–Derived Peptide, in Heart Failure (2022) (4)
- Twelve Lead Electrocardiographic Findings Among Māori and non-Māori at Risk of Cardiovascular Disease in NZ (2013) (4)
- Can circulating biomarkers identify heart failure patients at low risk? (2015) (4)
- Cardiac motion and spillover correction for quantitative PET imaging using dynamic MRI (2019) (4)
- Mildly reduced preoperative ejection fraction increases the risk of stroke in older adults undergoing coronary artery bypass grafting. (2012) (3)
- Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine. (2021) (3)
- Association of the aldosterone synthase gene C-344T polymorphism with risk factors and survival in a post-myocardial infarction cohort (2007) (3)
- Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes (2021) (3)
- Do the Natriuretic Peptides Cause Atrial Fibrillation or is it Not So Black and White? (2019) (3)
- FUNCTIONAL IRON DEFICIENCY IN HEART FAILURE WITH PRESERVED VERSUS REDUCED EJECTION FRACTION (2014) (3)
- Management of non ST-elevation acute coronary syndrome patients in New Zealand: a longitudinal analysis. Results from the New Zealand Acute Coronary Syndrome national audits of 2002, 2007 and 2012. (2016) (3)
- The diabetes-atrial fibrillation paradox (2019) (3)
- A man with severe, transient hypertension due to acute renal infarction (1999) (3)
- Lipid profiles and outcomes of patients with prior cancer and subsequent myocardial infarction or stroke (2021) (3)
- Adrenomedullin 2 attenuates the pressor but not adrenal responses to angiotensin II in conscious sheep (2010) (3)
- Infusion or co-infusion of brain natriuretic peptide and/or adrenomedullin in human heart failure (1998) (3)
- Subclinical vasculopathy and skeletal muscle metrics in the singapore longitudinal ageing study (2021) (3)
- Potassium abnormalities in patients with heart failure from 11 Asian regions: insights from the ASIAN‐HF registry (2019) (3)
- HYPONATREMIA, NATRIURETIC PEPTIDES AND OUTCOMES IN ACUTELY DESTABILIZED HEART FAILURE (2010) (3)
- Screening and treatment of obstructive sleep apnea in acute coronary syndrome. A randomized clinical trial. (2020) (3)
- Brain natriuretic peptide‐guided management of chronic heart failure: first do no harm (2013) (3)
- Heart rate score, a measure related to chronotropic incompetence in pacemaker patients (2021) (3)
- Biomarkers for Heart Failure in Asia. (2015) (3)
- A novel troponin T peptide in humans: Assay, biochemistry and preliminary findings in acute coronary syndromes. (2015) (3)
- Changes in plasma atrial natriuretic factor during sequential fluid removal and biochemical correction in end-stage chronic renal failure patients. (1990) (3)
- Abstract 17991: Markers of Acute Neutrophil Activation are Significantly Correlated with Elevated Plasma Human Neutrophil Elastase Levels at The Culprit Coronary Lesion Following Acute Occlusive Plaque Disruption an Acute ST Elevation Myocardial Infarction (2012) (3)
- Plasma Clearance of B-Type Natriuretic Peptide (BNP) before and after Bariatric Surgery for Morbid Obesity. (2020) (3)
- The Contrasting Relationships between Betaine and Homocysteine in Two Clinical Cohorts are Associated with Plasma Lipids and Drug Treatments (2012) (3)
- Natriuretic peptides : Research in New Zealand (1995) (3)
- High-sensitivity troponin T and long-term adverse cardiac events among patients presenting with suspected acute coronary syndrome in Singapore. (2019) (3)
- DOOR-TO-BALLOON TIME CORRELATES BETTER WITH PATIENTS OUTCOMES THAN SYMPTOM-TO-BALLOON TIME (2016) (3)
- Adrenomedullin in heart failure: potential therapeutic implications. (2005) (3)
- Prediction of ACC/AHA Stage B heart failure by clinical and neurohormonal profiling among patients in the community. (2010) (3)
- Clinical use of beta-blocker therapy in patients with heart failure: a practical guide. (2001) (3)
- Adrenomedullin augments the neurohumoral response to haemorrhage in non-pregnant but not in pregnant sheep. (2001) (3)
- Aging-induced isoDGR-modified fibronectin activates monocytic and endothelial cells to promote atherosclerosis (2021) (3)
- Monday, 27 August 2012 (2012) (3)
- C-Type Natriuretic Peptide and Cardiac Fibrosis (2011) (3)
- HUMAN CEREBRAL ARTERIO-VENOUS VASOACTIVE EXCHANGE DURING ALTERATIONS IN ARTERIAL BLOOD GASES RUNNING TITLE: CEREBRAL VASOACTIVE AGENTS AND ARTERIAL BLOOD GASES (2008) (3)
- The ‘Peptide for Life’ Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe (2021) (3)
- Effect of Human Atrial Natriuretic Peptide in Normal and Hypertensive Humans (1987) (3)
- Physicians’ Perception of the Patient Care Pathway for Acute Heart Failure in Asian Countries: Implications for Resource Allocation, Preventive Strategies and Clinical Trial Design (2014) (2)
- Sex Differences in 1-Year Rehospitalization for Heart Failure and Myocardial Infarction After Primary Percutaneous Coronary Intervention. (2019) (2)
- Therapeutic potential of infused cardiac natriuretic peptides in myocardial infarction (2009) (2)
- Cardiotrophin-1: a new cardiac marker? (2000) (2)
- Distinctive pattern of LET-7B and MIR-30B in human aortic smooth muscle cells of myocardial infarction patients. (2017) (2)
- Cardiac and renal biomarkers in recreational runners following a 21 km treadmill run (2020) (2)
- Plasma Alpha Human Atrial Natriuretic Peptide (ANP) in Sodium Replete and Deplete Normal Man (1986) (2)
- Incidence and predictors of side-branch compromise in primary percutaneous coronary intervention for acute myocardial infarction. (2014) (2)
- Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology (2022) (2)
- A Study Comparing Diagnostic Accuracy of High Sensitivity Assays of Troponin I and Troponin T for Myocardial Infarction Within Two Hours of Presentation to the Emergency Room (2013) (2)
- Angiotensin 2 Type 1 Receptor Blockade with Neprilysin Inhibition for Chronic Heart Failure: A New Paradigm? (2015) (2)
- Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure. (2004) (2)
- POTASSIUM SUPPLEMENTS AND HYPERTENSION (1984) (2)
- Cardiac mesh morphing method for finite element modeling of heart failure with preserved ejection fraction. (2021) (2)
- Abstract 18066: Elevated Levels of Circulating MicroRNA-223, MicroRNA-127 and MicroRNA-146a are Associated with Risk of Near Future Cardiovascular Events in Asymptomatic Individuals (2014) (2)
- Diagnostic and prognostic performance of the ratio between high-sensitivity cardiac troponin I and troponin T in patients with chest pain (2022) (2)
- Chapter 194 – Urocortins (2013) (2)
- MODERATE SODIUM RESTRICTION AND POTASSIUM SUPPLEMENTATION IN ESSENTIAL HYPERTENSION (1984) (2)
- Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction (2022) (2)
- The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS): Design and Methodology (2021) (2)
- Abstract W P194: Improved Efficacy of ICM Detection of Atrial Fibrillation in Cryptogenic Stroke Patients with MRI-Defined Infarcts: Preliminary Results from the SPIDER Registry (2015) (2)
- Guía de supervivencia para enfermería hospitalaria (2010) (2)
- Association between endothelin type A receptor haplotypes and mortality in coronary heart disease. (2012) (2)
- PT081 Functional iron deficiency in heart failure with preserved versus reduced ejection fraction (2014) (2)
- Prevalence and Prognostic Significance of Frailty in Asian Patients With Heart Failure (2021) (2)
- Changes in Body Electrolytes, Extracellular Fluid Volumes and Atrial-Natriuretic-Peptide During Development of Acth and Cortisol Excess in Man (1986) (2)
- Effects of alpha-human natriuretic peptide on microhaematocrit in normal subjects, essential hypertensives and patients with end-stage chronic renal failure (1987) (2)
- Erythroferrone can Diagnose Acute Decompensated Heart Failure in Patients Presenting With Breathlessness (2018) (2)
- Hemodynamic, Hormonal, and Renal Actions of Adrenomedullin-5 in Normal Conscious Sheep (2011) (2)
- The common G-866 A polymorphism of the UCP 2 gene and survival in diabetic patients following myocardial infarction (2015) (2)
- P6601Low miR-19b-1-5p expression in ACS patients is related to aspirin resistance and major adverse cardio-cerebrovascular event (MACCE) (2019) (2)
- A novel adaptive insertable cardiac monitor algorithm improves the detection of atrial fibrillation and atrial tachycardia in silico (2021) (2)
- Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations (2022) (2)
- Tailored therapy for heart failure: neurohormones. (2011) (2)
- Atrial natriuretic factor and the heart in health and disease. (1988) (2)
- Outcomes of a multi-ethnic Asian population on combined treatment with clopidogrel and omeprazole in 12,440 patients (2021) (2)
- Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry (2018) (2)
- Urotensin II is a relevant vasoactive mediator of cirrhotic portal hypertension in humans (2006) (2)
- Further studies are needed to assess the benefits of telemonitoring and telephone support for people with heart failure. Commentary. (2005) (2)
- Biomarkers and silent cardiac disease in primary prevention: time to unmask the damage? (2012) (2)
- Plasma cardiac natriuretic peptide levels in screening for cardiac disease. (2004) (2)
- High prevalence of iron deficiency in heart failure with preserved ejection fraction (2015) (2)
- Low-dose B-type natriuretic peptide raises cardiac sympathetic nerve activity in sheep. (2014) (2)
- A review from the Biomarkers Working Group of the Heart Failure Association of the ESC: A review from the Biomarkers Working Group of the Heart Failure Association of the ESC. (2022) (2)
- Progress in Proteomic Probing for Pathogenic Pathways in HFpEF. (2021) (1)
- Gold lung. (1982) (1)
- EXTRAUTERINE GESTATION AT TERM WITH HEALTHY BABY (1929) (1)
- Adrenomedullin 2 increases cardiac sympathetic nerve activity in parallel to heart rate in normal conscious sheep (2019) (1)
- Atrial Natriuretic Factor Administered to Humans: 1984‐1988 (1988) (1)
- Disease monitoring of patients with chronic heart failure (2007) (1)
- Assays Specific for BNP1-32 and NT-proBNP Exhibit a Similar Performance to Two Widely Used Assays in the Diagnosis of Heart Failure. (2022) (1)
- Heparin, But Not Bilvalirudin, Liberates Endothelial Myeloperoxidase in Patients with ST Elevation Myocardial Infarction (STEMI) (2007) (1)
- B‐type natriuretic peptides: applications for heart failure management in 2005 (2005) (1)
- The Lower Rate Limit for Pacing by Cardiac Resynchronization Defibrillators: Should Lower Rate Programming be Reconsidered? (2021) (1)
- Chronic Urocortin 2 Treatment Significantly Improves Cardiovascular Function and Attenuates Cardiac Injury and Remodelling after Experimental Myocardial Infarction (2010) (1)
- Use of sex-specific cut-offs with highly sensitive troponin I assay values for the diagnosis of acute myocardial infarction in emergency patients with chest pain (2013) (1)
- Abstract 1812: The Chromosome 9p21.3 Coronary Artery Disease Risk Locus is Associated with Altered Cardiac Gene Expression in Individuals without Overt Cardiac Abnormality (2008) (1)
- ASSOCIATION OF ETHNICITY, AGE AND BODY SIZE WITH ELECTROCARDIOGRAPHIC VALUES IN THE COMMUNITY (2014) (1)
- Screening for Cardiovascular Disease in Maori Communities: The Community Heart Study (2009) (1)
- Integrated Effects of Urocortin-2 Infusion in Patients with Acute Decompensated Heart Failure: Findings from a Randomised Controlled Clinical Trial (2012) (1)
- OBSTRUCTIVE SLEEP APNEA IS ASSOCIATED WITH VISIT-TO-VISIT VARIABILITY IN LOW DENSITY LIPOPROTEIN-CHOLESTEROL IN PATIENTS WITH CORONARY ARTERY DISEASE (2016) (1)
- Diagnosis of AMI Using Sex-Specific Cut-Off Values of a Highly Sensitive Troponin I Assay in Emergency Department Patients With Chest Pain (2013) (1)
- Relationship of plasma BNP levels to tissue doppler and color M-mode indices of diastolic function and left ventricular filling pressure in systolic heart failure (2003) (1)
- Soluble urokinase plasminogen activator receptor (suPAR) can predict long-term mortality in patients with acute chest pain (2020) (1)
- Abstract 268: Through the Inhibition of Autophagy Flux miR-221 Plays an Important Role in the Reductions of Hypoxia Reoxygenation Induced Cell Death and Collagen Synthesis in Cardiac Fibroblast (2018) (1)
- Systemic angiotensin II does not increase cardiac sympathetic nerve activity in normal conscious sheep (2018) (1)
- Atrial natriuretic peptides: endogenous diuretics? (1985) (1)
- Bioactivity of natriuretic peptide coinfusions; no evidence for unique effects of BNP in conscious sheep. (1999) (1)
- Age-related differences in ventricular remodeling and long-term heart failure outcomes following acute coronary syndrome (2020) (1)
- Emerging microRNA biomarkers for acute kidney injury in acute decompensated heart failure (2020) (1)
- Endothelin-induced changes in intracellular calcium concentration in rat vascular smooth muscle cells: Effects of extracellular calcium and atrial natriuretic factor (2005) (1)
- Prediction of cardiac rhythm 1 year following cardioversion for atrial fibrillation. (2011) (1)
- Comparing conventional and high sensitivity troponin T measurements in identifying adverse cardiac events in patients admitted to an Asian emergency department chest pain observation unit (2021) (1)
- Effect of sex steroids on plasma CNP forms: stimulation by oestradiol in (2008) (1)
- Urocortin 1 modulates the neurohumoral response to acute nitroprusside-induced hypotension in sheep. (2007) (1)
- Nitrates in combination with hydralazine in cardiorenal syndrome: a randomized controlled proof‐of‐concept study (2020) (1)
- On-pump transapical cardioscopic mitral valve replacement with cardiac arrest: short-term results in a porcine survival model. (2018) (1)
- Correction: Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection (2017) (1)
- Sleep study–guided multidisciplinary therapy (SGMT) for patients with acute coronary syndrome: Trial rationale and design (2018) (1)
- MicroRNA expression profiles of human left ventricle derived cardiac cells in normoxic and hypoxic conditions (2015) (1)
- Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in ambulent sheep (2007) (1)
- P mino-Terminal Pro-Brain Natriuretic Peptide , enal Function , and Outcomes in Acute Heart Failure edefining the Cardiorenal Interaction ? (2006) (1)
- Abstract 15048: Circulating microRNAs as Diagnostic and Prognostic Markers for Heart Failure (2014) (1)
- New government, same narrow vision. Health authorities in New Zealand have spin doctors to produce good news. (1998) (1)
- The ASia-Pacific Evaluation of Chest pain Trial (ASPECT): two-hour emergency department rule-out evaluation for chest pain (2011) (1)
- Impairment in the number and function of CD34+/KDR+ circulating cells in diabetes and obesity with functional improvement after thymosin &bgr;4 treatment (2016) (1)
- Cardiac Natriuretic Peptides (2017) (1)
- Are Some Patients With Acute Heart Failure ANP-Deficient? (2019) (1)
- Hydrogen Sulfide and Substance P Levels in Patients with Escherichia coli and Klebsiella pneumoniae Bacteraemia (2022) (1)
- Natriuretic peptide system in fetal heart and circulation. (2002) (1)
- Prognostic value of sST2 in heart failure patients with diabetes (2021) (1)
- Augmentation of Natriuretic Peptide Bioactivity via Combined Inhibition of Neprilysin and Phosphodiesterase-9 in Heart Failure. (2022) (1)
- Sex differences in diabetic patients from the ASIAN-HF registry (2017) (1)
- Long-term Outcomes of Medical Therapy Versus Coronary Revascularisation in Patients with Intermediate Stenoses Guided by Pressure Wire. (2015) (1)
- Abstract 16095: Plasma NT-proBNP Concentrations are Two-fold Lower in Pacific versus European Population Samples: Evidence for Glycosylation Impacting Assay Detection and/or ProBNP Processing (2020) (1)
- Review A State of Natriuretic Peptide Deficiency. (2022) (1)
- Cardiac myosin‐binding protein C as a candidate biomarker in heart failure: rational but not revolutionary (2021) (1)
- Author Correction: Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation (2021) (1)
- Effects of Carotid Artery Stiffness on Cerebral Small‐Vessel Disease and Cognition (2022) (1)
- Harnessing the power of microRNAs as prognostic biomarkers in acute heart failure (2018) (1)
- Abstract 18392: Mir-101a and Tgf-β Are Mutually Inhibitory: Escape of Tgf-β From Mir-101a Inhibition Promotes Cardiac Fibrosis (2016) (1)
- Progress in proteomic probing for pathogenic pathways in heart failure with preserved ejection fraction (2021) (1)
- Plasma mid-regional pro-atrial natriuretic peptide is associated with and improves prediction of lone atrial fibrillation (2013) (1)
- Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation (2020) (1)
- High-grade culprit lesions are a common cause of ST-segment elevation myocardial infarction. (2015) (1)
- AMPD1 gene polymorphism and survival in patients with stable congestive heart failure. (2007) (1)
- Corrigendum to: ‘Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction’ (2008) (1)
- Enhanced Thrombin Generation Is Associated with Worse Left Ventricular Scarring after ST-Segment Elevation Myocardial Infarction: A Cohort Study (2022) (1)
- Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum. (2017) (1)
- Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF. (2023) (1)
- Relationship between CHA(65)DS(2) score and obstructive sleep apnea (CHA(65)DS(2) and OSA). (2013) (1)
- Prognostic Value of Left Atrial Strain in Aortic Stenosis: A Competing Risk Analysis. (2022) (1)
- Plasma tissue factor coagulation activity in post-acute myocardial infarction patients (2022) (1)
- Pathophysiologic mechanism for MYOcarditis in COVID-19 VAccinations ("MYOVAx" Study) (2023) (1)
- 266Loss of pumilio 1 phosphorylation turns off the regulation of miRNA-221 on gene p27kip1 in the heart (2019) (1)
- Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety (2022) (1)
- Loss of full-length pumilio 1 abrogates miRNA-221-induced gene p27 silencing-mediated cell proliferation in the heart (2021) (1)
- P2674Rapid rule-out of myocardial infarction with a novel high precision point-of-care troponin assay appears safe and effective (2019) (1)
- 41 Circulating levels and prognostic cut-offs of sST2, high-sensitivity troponin T, and NT-proBNP in women vs. men with chronic heart failure (2021) (1)
- Loose tobacco, ethnicity, income and rurality (2012) (1)
- Postdocs as Key to Faculty Diversity: A Structured and Collaborative Approach for Research Universities (2022) (1)
- Cardiac biomarkers retain prognostic significance in patients with heart failure and chronic obstructive pulmonary disease. (2021) (1)
- Left ventricular ejection fraction in addition to N-terminal pro-B-type natriuretic peptide for risk stratification in the ambulant elderly: get the picture...or not? (2011) (1)
- ST2 Measurement Predicts Death and Heart Failure in Patients Presenting to the Emergency Department with Chest Pain (2011) (1)
- Management of non ST-elevation acute coronary syndrome (NSTEACS) patients in New Zealand (NZ): A longitudinal analysis. Results from the NZACS national audits of 2002, 2007 and 2012 (2014) (1)
- Funding of biomedical research in New Zealand. (2000) (1)
- P3408The signal peptide of CNP is a novel predictor of MI, MACE and bleeding risk in chest pain patients (2019) (0)
- N-terminal brain natriuretic peptide predicts symptomatic status and severity of mitral regurgitation in patients with mitral regurgitation (2002) (0)
- Abstract 11712: Plasma Mid-Regional Pro-Atrial Natriuretic Peptide and N-terminal Pro-Brain Natriuretic Peptide Improve Discrimination of Lone Atrial Fibrillation (2014) (0)
- Prevalence and Clinical Signi fi cance of Diabetes in Asian Versus White Patients With Heart Failure (2016) (0)
- Abstract 15090: Circulating miR-503 and miR-374b-5p are associated With Heart Failure (2015) (0)
- Low Mir-19B-1-5P Expression In Acs Patients Is Related To Aspirin Resistance And Major Adverse Cardio-Cerebrovascular Event (Macce) (2019) (0)
- Local leukocyte elastase release at site of occlusive plaque rupture predicts downstream microvascular reperfusion injury and impaired left ventricular function in ST elevation myocardial infarction (2008) (0)
- Thepharmacokinetics ofquinapril andquinaprilat in patients withcongestive heart failure (1994) (0)
- Abstract 14322: Improvement of Endothelial Progenitor Cell Number and Function in Obesity and Diabetes With Thymosin Beta-4 (2013) (0)
- Abstract 15938: E/Em and Plasma BNP Predict Adverse Cardiovascular Outcome in Predialysis Chronic Kidney Disease: A Prospective Cohort Study (2011) (0)
- Abstract 2375: NT-proBNP Should be Used in the Definition of the "Cardio-Renal Syndrome" (2006) (0)
- Abstract 54: MicroRNA Let-7d-3p in Heart Failure (2016) (0)
- REDUCED ENDOTHELIAL PROGENITOR CELL NUMBER AND FUNCTION IN DIABETES AND OBESITY WITH IMPROVEMENT IN MIGRATION CAPACITY AND TUBULE FORMATION FROM THYMOSIN BETA–4 TREATMENT (2013) (0)
- Transcriptomic responses associated with kidney injury and repair in acute decompensated heart failure (2020) (0)
- Erratum: Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: Comparison with normal sheep (Journal of the American College of Cardiology (2002) 40 (1495-1505)) (2003) (0)
- Sa1731 Proton Pump Inhibitor and Clopidogrel Interactions in an Asian Population (2015) (0)
- Abstract 3384: Amino-terminal pro-Brain Natriuretic Peptide Testing is Superior to New York Heart Association Classification for Prediction of One-Year Mortality in Patients with Acute Heart Failure: Results from the International Collaborative of NT-proBNP Study (2006) (0)
- P4619Accelerated accrural of ischaemic events after stopping dual antiplatelet therapy at 12 months in a real-world acute myocardial infarction cohort (2018) (0)
- Abstract 19750: Cardiac Biomarkers and MicroRNAs as Predictors of Cardiovascular Events in Asymptomatic Individuals (2017) (0)
- Renin-angiotensin system inhibition and In-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: Findings from CCC-ACS project and a nationwide electronic health record-based cohort in China. (2023) (0)
- pituitary \ p = n-\ adrenal axis response to coronary artery embolization : an ovine model of acute myocardial infarction (0)
- Predictive value of novel biomarkers for response to medical treatment in systolic heart failure (2013) (0)
- Abstract 15514: Twelve-Year Predictive Value of Acute Heart Failure Among 15,151 Patients With Acute Myocardial Infarction (2013) (0)
- Abstract 9920: Growth Differentiation Factor 15, ST2 and Natriuretic Peptides in Heart Failure with Preserved versus Reduced Ejection Fraction (2011) (0)
- O009 Iron deficiency in a multi-ethnic Asian population with heart failure (2014) (0)
- Abstract 16470: Identification of Microrna in an Ovine Model of Heart Failure (2014) (0)
- Natriuretic Peptides for Disease Monitoring in Patients with Chronic Heart Failure (2009) (0)
- Sleep study guided multidisciplinary therapy for acute coronary syndrome: a randomized trial (2019) (0)
- Urocortin 2: Neurohumoral Mechanisms in Heart Disease (2012) (0)
- Apolipoprotein E isoforms are associated with age of onset of coronary disease but not subsequent mortality in a coronary disease cohort (2010) (0)
- Fourteen Year Follow-up after Direct Percutaneous Intervention (DPCI) with Remote Surgical Backup for Anterior ST elevation myocardial infarction (STEMI) (2010) (0)
- P5719Plasma proteomics identify plaque-related proteins that predict long-term recurrent coronary events in patients with acute coronary syndrome (2019) (0)
- 670 Urocortin 1 exhibits potent inhibition of cardiac sympathetic nerve activity in ambulant sheep (2007) (0)
- Authors' response (2012) (0)
- Correction (1990) (0)
- A051 Long-term Outcomes for Patients with Heart Failure in New Zealand according to Ejection Fraction Phenotype (2020) (0)
- Abstract 318: Targeting of Tp53inp1 by Mir-221 to Reduce P62-mediated Autophagy is Cardioprotective in Ischemia / Reperfusion Injury (2015) (0)
- Heart rate score predicts mortality independent of shocks in ICD and CRT-D patients (2019) (0)
- Plasma Alpha Human Natriuretic Peptide (ANP) during Exercise in Sodium Replete and Deplete Normal Man (1986) (0)
- Abstract 17729: Expression Profiles of Circulating MicroRNA in Heart Failure With Reduced and Preserved Ejection Fraction in Asia Population (2013) (0)
- Core services and cardiac surgery. (1995) (0)
- Serial platelet reactivity in patients undergoing early invasive management for acute coronary syndrome (2013) (0)
- Prognostic performance of soluble urokinase plasminogen activator receptor for 1-year mortality in Asian and Western patients with acute breathlessness (2020) (0)
- P4761Genetic risk variants for heart failure onset and progression do not improve prediction of mortality beyond established prognostic neurohormonal and echocardiographic markers (2018) (0)
- The Investigation and Treatment of Women who Present with Acute Chest Pain, Varies Little Compared with Men when Stratified by Risk (2018) (0)
- The protection of urocortin 2 against ischemia/reperfusion injury is due to p38 MAPK down‐regulation in an isolated rat heart model (2013) (0)
- B012: Hyponatremic-hypertensive syndrome in renal ischemia: An under-recognised disorder (1998) (0)
- 1119-97 Prognostic value of circulating B-type natriuretic peptide in patients with stable coronary artery disease (2004) (0)
- Acute Myocardial Infarction Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction (2016) (0)
- 1096Mid regional atrial natriuretic peptide is an independent predictor of peak pulmonary capillary wedge pressure in patients with heart failure with preserved ejection fraction (2018) (0)
- Basic Science and Experimental Studies (Pro)renin Receptor Blockade Ameliorates Cardiac Injury and Remodeling and Improves Function After Myocardial Infarction (2016) (0)
- ANP bioactivity in obese hypertensives. (1999) (0)
- Prevalence and Clinical Characteristics of Heart Failure Medical Treatment Non-responders (2014) (0)
- Insulin signal peptide fragment biomarkers (2009) (0)
- P2791The TNF receptor TACI is a novel inflammatory predictor of heart failure (2018) (0)
- Predictors and Ramifications of Worsening Renal Function in Acutely Destabilized Heart Failure: Results from the ICON Study (2009) (0)
- Increased isoDGR motifs in plasma fibronectin are associated with atherosclerosis through facilitation of vascular fibrosis (2020) (0)
- Natriuretic Peptide Goal-Directed Therapy: Are We There Yet? (2015) (0)
- THE IMPACT OF THE QTC INTERVAL ON MORTALITY AND CARDIOVASCULAR OUTCOMES: A POPULATION-BASED STUDY IN HEALTHY ASIANS (2016) (0)
- 126 CHROMOSOME 9P21 LOCUS AND ANGIOGRAPHIC CORONARY ARTERY DISEASE BURDEN: A COLLABORATIVE META-ANALYSIS (2013) (0)
- Circulating microRNAs as markers for prediction of heart failure medical treatment outcome (2013) (0)
- Comparative performances of soluble urokinase plasminogen activator receptor and Mid-regional proADM to predict composite death and new heart failure rehospitalisation in acutely breathless patients (2022) (0)
- Abstract 11710: Plasma Mid-Regional Pro-Atrial Natriuretic Peptide and N-terminal Pro-Brain Natriuretic Peptide Can Discriminate Between Paroxysmal and Persistent Lone Atrial Fibrillation (2014) (0)
- Abstract 16495: A New Approach to Select Novel Potential Therapeutic Mirna Targets Effectively in the Cardiac Protection of Ischemia/Reperfusion (i/r) Injury (2014) (0)
- New Zealand priority criteria project. Project has potential to improve patient care, but only with injection of funds. (1997) (0)
- A054 Age-Related Differences in Ventricular Remodeling and Long-Term Heart Failure Outcomes Following Acute Coronary Syndrome (2020) (0)
- S4-2 Gene Polymorphisms in Patients with Heart Failure and Acute Coronary Syndromes (2009) (0)
- INDEPENDENT PROGNOSTIC SIGNIFICANCE OF GROWTH DIFFERENTIATION FACTOR 15 IN HEART FAILURE WITH PRESERVED VERSUS REDUCED EJECTION FRACTION (2013) (0)
- Continuous recording ofpulmonary artery pressurein unrestricted subjects (1984) (0)
- plasma catecholamines . relation to systemic arterial pressure , and primary pulmonary hypertension : variability , Ambulatory pulmonary arterial pressure in (2004) (0)
- Abstract 20232: Circulating MicroRNAs Associated With Cardiovascular Disease Do Not Improve Prediction of Incident Cardiovascular Events Within Five Years in Asymptomatic Individuals (2016) (0)
- What Predicts Troponin Release in Acutely Decompensated Heart Failure (2009) (0)
- Growth differentiation factor 15, ST2 and natriuretic peptides in heart failure with preserved and reduced ejection fraction (2012) (0)
- 259 BRAIN NATRIURETIC PEPTIDE AT NON HYPOTENSIVE DOSES RAISES CARDIAC SYMPATHETIC NERVE ACTIVITY IN SHEEP (2012) (0)
- The 99th percentile of an updated heart fatty acid binding protein assay combines with high sensitive troponin I to rule out acute myocardial infarction on presentation to the emergency department (2015) (0)
- Prognostic value of NT-proBNP and best cut-offs for risk prediction in obese patients with chronic systolic heart failure (2020) (0)
- Difference in clinical outcomes between patients who underwent left main stenting during elective versus emergency setting (2013) (0)
- Abstract 319: Mirna-125b Reduces Ischemia / Reperfusion (i/r)-induced Apoptosis Through Targeting Multiple Targets in Intrinsic and Extrinsic Apoptosis Pathways (2015) (0)
- Abstract 1882: Chromosome 6q25.1 and 2q36.3 Coronary Heart Disease Risk Loci Are Associated With Altered Cardiac Gene Expression Profiles in Normal Heart (2009) (0)
- Abstract 14346: Short Term Hyperglycaemia Impair Endothelial Progenitor Cells With Improvement After Thymosin Beta-4 Treatment (2013) (0)
- Moderate endurance exercise is associated with an abnormal cardio-renal response in recreational runners (2013) (0)
- All Cause Mortality Following an Acute Coronary Syndrome (ACS) Admission: Six Year Follow-up of the 2002 New Zealand (NZ) Acute Coronary Syndromes Audit (2012) (0)
- Proteomic probing for markers and mechanisms in Heart Failure. (2021) (0)
- Hypertension and cardiovascular events after myocardial infarction (2000) (0)
- Prior Cancer Is Associated with Lower Atherosclerotic Cardiovascular Disease Risk at First Acute Myocardial Infarction (2022) (0)
- Brain free‐water increases mediate the association of blood cardiovascular biomarkers with longitudinal cognitive decline in prodromal and clinical dementia (2020) (0)
- Abstract 15349: Circulating Glycosphingolipids Primarily Correlate With LDL-C but Not HDL-C or TG and Are Associated With Disease Severity in Acute Myocardial Infarction (2016) (0)
- sFlt-1 and NTproBNP independently predict mortality in a cohort of heart failure patients. (2018) (0)
- Urocortin has beneficial hemodynamic, endocrine and renal effects in experimental heart failure (2002) (0)
- Plasma Myeloperoxidase at the Culprit Coronary Lesion in Acute Myocardial Infarction (2009) (0)
- THE ASSOCIATION OF BLOOD MARKERS OF CARDIAC DYSFUNCTION AND CORTICAL CEREBRAL MICROINFARCTS ON 3-TESLA MAGNETIC RESONANCE IMAGING (2016) (0)
- The Effects of Alpha Human Atrial Natriuretic Peptide (ANP) in Essential Hypertension (1986) (0)
- P2582Signature of plasma extracellular vesicles associated proteins in acute myocardial infarction patients (2019) (0)
- Immunoreactive BNP-Signal Peptide: A Potential Early Biomarker of AMI (2008) (0)
- Scope of the review : recent progress in the generation of cardiovascular disease models (2015) (0)
- List of Potential Supervisors and Projects available for Laboratory Rotation – August 2017 intake Category : Cardiovascular Disease Department of Medicine Principal Investigator Project Title with a brief description Prof (2017) (0)
- THREE-YEAR FOLLOW-UP OF PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION WHO RECEIVED ENDOTHELIAL PROGENITOR CELL CAPTURE STENT WHILE UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (2012) (0)
- Abstract 18372: Platelet Reactivity Measurements Before and After Percutaneous Coronary Intervention Among Patients Undergoing Early Invasive Management for Acute Coronary Syndrome (2013) (0)
- Abstract 15653: Treatment With miRNA-101a Prevents Sustained Hypertension-induced Cardiac Fibrosis and Loss of Cardiac Function via Actions as an Endogenous Inhibitor of TGF-β Signaling (2017) (0)
- Prognostic modelling of clinical outcomes after first-time acute coronary syndrome in New Zealand (2023) (0)
- New Zealand Core Services Committee repeats mistakes of JNC V. (1995) (0)
- A M RICHARDS, J G F CLELAND, G TONOLO, G D McINTYRE, B J LECKIE, H J DARGIE, S G BALL, J I S ROBERTSON (2016) (0)
- Natriuretic peptide plasma levels remain elevated six months after aortic valve replacement for severe aortic stenosis (2003) (0)
- Prognostic Performance of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Predicting Mortality in Asian and Western Patients With Acute Breathlessness (2021) (0)
- Special Report The International Standard for Atrial Natriuretic Factor Calibration by an International Collaborative Study (2005) (0)
- Abstract 15421: Effect of Weight Loss Intervention Program on Cardiac Function, Endothelium Progenitor Cells and Microparticles in Mildly Obese Asians (2016) (0)
- Association Between Diabetes, Chronic Kidney Disease, and Outcomes in People With Heart Failure From Asia (2023) (0)
- Clinical Trial: Methods and Design The Singapore Heart Failure Outcomes and Phenotypes (SHOP) Study and Prospective Evaluation of Outcome in Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PEOPLE) Study: Rationale and Design (2013) (0)
- Abstract 13115: Circulating MicroRNA-454-3p is Associated With Acute Kidney Injury in Patients With Acute Decompensated Heart Failure (2019) (0)
- P5379MiRNA-221 mimic selectively down-regulates targets under ischemic but not normal condition: evidences from in vivo myocardium infarction and ex vivo H9c2 ischemia (2017) (0)
- The relationship between glycosylation of proBNP at threonine 71, BNP, BNP1–32 and obesity in patients with heart failure (2020) (0)
- Abstract 100: Discovery of Cardiac Fibroblast Enriched microRNAs and Their Pivotal Roles in the Regulation of Cardiac Remodeling and Fibrosis (2016) (0)
- P4904Multi-ethnic comparisons of diabetes in heart failure with reduced ejection (2017) (0)
- Abstract 15520: Plasma Glycosylceramides as Prognostic Biomarkers in the Acute Myocardial Infarction (2018) (0)
- Atrial natriuretic peptide and body fluid homeostasis: leading actor or bit-part player? (1995) (0)
- The influence of renal impairment on the clinical utility of BNP as a diagnostic tool in suspected heart failure (2003) (0)
- Significant Delays to Access Cardiac Angiography for Acute Coronary Syndrome (ACS) Patients in New Zealand (NZ): A Comparison of the National 2002, 2007 and (Snapshot) 2012 ACS Audits (2013) (0)
- Converting enzyme inhibitors and renal function in cardiac failure. (1987) (0)
- Characterising a novel mouse model of the metabolic syndrome (2009) (0)
- The Urogenital System (2002) (0)
- The novel conserved NAD+-binding micropeptide SGHRT regulates mitochondrial function and metabolism in human cardiomyocytes (2021) (0)
- Characterization of Amino-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in Human Urine (2009) (0)
- Abstract 106: GYY4137 Attenuates Post-Ischemic Adverse Remodeling and Modulates ANP-Mediated cGMP Signal Transduction (2014) (0)
- 263Through differential targeting of cardiac myocytes and fibroblasts, miR-221 promotes myocardial recovery and averts adverse remodeling after infarction (2019) (0)
- Abstract 107: MicroRNA-31: A Novel Therapeutic Target for Ischemic Heart Disease (2014) (0)
- Neurohormonal factors in the pathogenesis of essential hypertension (1996) (0)
- 150 ProBNP glycosylation of threonine 71 is increased with obesity in patients with heart failure (2020) (0)
- How does neprilysin inhibition in heart failure work? (2019) (0)
- Optimizing the diagnostic utility of N‐terminal pro‐B‐type natriuretic peptide for acute heart failure in obesity and beyond (2022) (0)
- Urinary peptides in heart failure – the need for care with pees and cues (2021) (0)
- Endothelial Damage Arising From High Salt Hypertension Is Elucidated by Vascular Bed Systematic Profiling (2023) (0)
- Regional Focus Series: Research in New Zealand (1995) (0)
- Relationship of N-BNP with hospital admission in elderly symptomatic patients in the community: follow up from the natriuretic peptides in the community study (2003) (0)
- No smoke without fire? (2016) (0)
- Finding a reliable assay for soluble neprilysin. (2022) (0)
- The under-recognized differences in late outcomes following acute myocardial infarction among Asian ethnicities in Singapore (2013) (0)
- Socio-economic factors and outcomes in heart failure: Insights from the ASIAN-HF registry (2018) (0)
- Abstract 17557: Programmed Lower Rate Limit in Cardiac Resynchronization Therapy Defibrillators: Is There One Best Approach? (2015) (0)
- BNP Signal Peptide and High Sensitivity Troponin T Response During Dobutamine Stress Echocardiography (2011) (0)
- Plasma Myeloperoxidase Levels are Highest in the Infarct-Related Artery (IRA) in Patients with ST Elevation MI (2007) (0)
- ASPECT (ASia Pacific Evaluation of Chest pain Trial) – New Zealand ARM (2010) (0)
- ETHNICITY AND SEX-SPECIFIC ECHOCARDIOGRAPHIC AND ELECTROCARDIOGRAPHIC CRITERIA FOR LEFT VENTRICULAR HYPERTROPHY: COMMUNITY-BASED DATA FROM AN ASIAN POPULATION (2014) (0)
- PREVALENCE AND EVOLUTION OF SLEEP DISORDERED BREATHING IN ACUTE MYOCARDIAL INFARCTION (2017) (0)
- Abstract TMP40: Impact of Age on Atrial Fibrillation Detection among a Large, Real-World Population of Cryptogenic Stroke Patients with Insertable Cardiac Monitors (2016) (0)
- URINARY PROTEINS LEVELS ASSOCIATED WITH OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (2023) (0)
- Urocortin-2 Increases Muscle Sympathetic Nerve Activity [MSNA] in Healthy Man (2012) (0)
- Examining Rural Resources and Readiness to Change the Context for Obesity Prevention (2016) (0)
- Abstract 13054: Thymosin Beta-4-Treated Endothelial Progenitor Cells Improve Cardiac Function and Vasculogenesis in Diabetic Obese Rats with Myocardial Infarction (2014) (0)
- CIRCADIAN DEPENDENCE OF INFARCT SIZE AND CLINICAL OUTCOMES IN 6,710 PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION (2014) (0)
- 13 Neutrophil activation at the culprit lesion in acute ST-segment elevation myocardial infarction with multiple complex coronary plaques (2011) (0)
- Abstract 11775: Change in Circulating Mir-652 Predicts Mortality in Patients with Acute Coronary Syndromes (2012) (0)
- Abstract W P287: Collaborative Cryptogenic Stroke Clinic Improves Secondary Stroke Prevention While Helping Achieve Stroke Metrics (2015) (0)
- P263 Characterisation of patients with acute myocardial infarction complicated by left ventricular thrombus (2020) (0)
- Dual Platelet Reactivity Testing in Acute Coronary Syndrome (2016) (0)
- Metabolic Syndrome Alters Expression Levels of Metabolic Disease Risk Loci Genes (2010) (0)
- Abstract 9552: A Novel Human Cardiac Troponin T upstream Open Reading Frame Peptide Assists in the Diagnosis and Prognosis of NSTEMI Patients (2013) (0)
- C type natriuretic peptide (CNP) in acute coronary syndrome (ACS): prognostic value and relation to cardiac and renal function at baseline (2015) (0)
- Blood‐based cardiac biomarkers and the risk of cognitive decline, vascular events and mortality (2020) (0)
- P1756The protein APRIL predicts adverse outcomes in DAPT patients better than NT-proBNP and troponin (2019) (0)
- Abstract 2559: A Validated Clinical and Biochemical Risk Score for Prediction of One-Year Mortality in Dyspneic Emergency Department Patients: The ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Mortality Risk Score (2006) (0)
- Improving Interventional Management of Acute Coronary Syndrome (ACS) Patients in New Zealand (NZ): A Comparison of the 2002, 2007 and 2012 National ACS Audits (2013) (0)
- [Not Available]. (2010) (0)
- PROTEOMIC ASSOCIATIONS OF N-TERMINAL (NT)-PRO HORMONE BNP (NT-PROBNP) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) (2023) (0)
- Diagnostic accuracy of highly sensitive troponin I versus highly sensitive troponin T assays for acute myocardial infarction within two hours of emergency department presentation (2013) (0)
- PROTEOMIC CORRELATES OF PLASMA POTASSIUM (K+) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) (2023) (0)
- 135 An improved ejection fraction parameter capable of representing cardiac function regardless of heart morphology to distinguish hfpef from normal hearts (2021) (0)
- The Acute Throat (1949) (0)
- Feature-tracking global longitudinal strain has prognostic value in heart failure patients with diabetes (2023) (0)
- Risk of sudden cardiac death following acute coronary syndromes: Interplay of single nucleotide polymorphisms and the presence of heart failure (2014) (0)
- Flow dynamics and energy efficiency of flow in the left ventricle during myocardial infarction (2017) (0)
- The Johann Jacob Wepfer Award 2015 of the European Stroke Conference to Professor Ralph L. Sacco (2015) (0)
- Impact of Diabetes Mellitus on Myocardial Fibrosis in Patients with Hypertension: the REMODEL Study (2023) (0)
- ST2 PREDICTS HEART FAILURE AND ALL CAUSE MORTALITY IN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH CHEST PAIN (2011) (0)
- Echocardiographic global longitudinal strain as a marker of myocardial fibrosis predicts outcomes in aortic stenosis (2021) (0)
- MULTIPLE CARDIAC EFFECTS OF ERYTHROPOIETIN: P2.66 (2004) (0)
- EARLY POST TRANSPLANT ANAEMIA IS NOT ASSOCIATED WITH THE ANGIOTENSIN II TYPE 1 A1166C SINGLE NUCLEOTIDE POLYMORPHISM OR ANGIOTENSIN CONVERTING ENZYME INSERTIN/DELETION POLYMORPHISM IN RENAL TRANSPLANTATION: 2247 (2008) (0)
- Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF Registry (2022) (0)
- An integrated signature of extracellular matrix proteins and a diastolic function imaging parameter predicts post-MI long-term outcomes (2023) (0)
- THE CORNELL PRODUCT IS A NOVEL ELECTROCARDIOGRAPHIC MARKER OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (2016) (0)
- Temporal Changes in Extracellular Vesicle Hemostatic Protein Composition Predict Favourable Left Ventricular Remodeling after Acute Myocardial Infarction (2022) (0)
- 1093Prognostic value of convalescent high-sensitivity troponin I concentrations following acute coronary syndrome (2018) (0)
- SHORTER DOOR-TO-BALLOON TIME IS ACCOMPANIED BY REDUCED HEART FAILURE AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION DESPITE A TEMPORAL INCREASE IN HEART FAILURE BEFORE PRIMARY PERCUTANEOUS CORONARY INTERVENTION (2016) (0)
- CHRONIC KIDNEY DISEASE IN ASIAN PATIENTS WITH HEART FAILURE (2017) (0)
- Morphological, Functional, and Biomechanical Progression of LV Remodelling in a Porcine Model of HFpEF (2022) (0)
- Diagnostic accuracy of the electrocardiogram for heart failure with reduced or preserved ejection fraction. (2023) (0)
- DIFFERENCES IN LATE CARDIOVASCULAR MORTALITY FOLLOWING ACUTE MYOCARDIAL INFARCTION AMONG THREE MAJOR ASIAN ETHNICITIES (2013) (0)
- Plasma Ceramides in Cardiovascular Disease Risk Stratification. (2022) (0)
- Electrocardiographic Left Ventricular ‘Strain’ Predicts Early Left Ventricular Dysfunction in Asymptomatic Aortic Stenosis (2007) (0)
- ADAPT Trial Symptoms Using Contemporary Troponins as the Only Biomarker: The 2-Hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain (2012) (0)
- Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients. (2023) (0)
- 60 Atrial natriuretic factor has biological effects in man at physiological levels (1988) (0)
- Late Stent Thrombosis After Xience Stent Implantation and Six Months of Clopidogrel (2009) (0)
- WORSE ONE-YEAR HEART FAILURE OUTCOMES AFTER NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION THAN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND TREATMENT IMPLICATIONS IN A NATIONWIDE STUDY OF 36,333 UNSELECTED PATIENTS HOSPITALIZED FOR ACUTE MYOCARDIAL INFARCTION (2018) (0)
- Sheep for the study of the urocortins and other hormones (2014) (0)
- PREDICTIVE VALUE OF INDEX OF MICROVASCULAR RESISTANCE MEASURED AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ON MYOCARDIAL SCARRING ON CARDIAC MAGNETIC RESONANCE AND LONG-TERM OUTCOMES IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION (2022) (0)
- Plasma multi-omic and cardiac imaging network signatures predict poor long-term outcomes after acute myocardial infarction (2022) (0)
- Increased Systemic and Local Neutrophil and Monocyte Degranulation in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST Elevation Myocardial Infarction (2008) (0)
- Guía de supervivencia para enfermería hospitalaria 2nd Edition (2010) (0)
- Comparison of SPEED, S-Trap, and In-Solution-Based Sample Preparation Methods for Mass Spectrometry in Kidney Tissue and Plasma (2023) (0)
- Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation (2021) (0)
- Effect of monthly vitamin D supplementation on cardiac biomarkers: A post-hoc analysis of a randomized controlled trial (2022) (0)
- 57 Contrasting plasma atrial natriuretic factor (ANF) concentrations and urine electrolyte profile during infusions of saline and human ANF-(99–126) in normal man (1988) (0)
- Identification of novel microRNAs in the sheep heart and their regulation in heart failure (2017) (0)
- Author Correction: Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation (2021) (0)
- One-Shot Generation of Epitope-Directed Monoclonal Antibodies to Multiple Nonoverlapping Targets: Peptide Selection, Antigen Preparation, and Epitope Mapping. (0)
- Ventricular arrhythmias in a mouse model of vinculin-related cardiomyopathy (2005) (0)
- A New Velocity Probe for Sensing Pulsatile Blood Flow (1959) (0)
- MicroRNA-143 modulates the expression of Natriuretic Peptide Receptor 3 in cardiac cells (2018) (0)
- OBSTRUCTIVE SLEEP APNEA AND DIABETES MELLITUS HAVE SYNERGISTIC EFFECTS ON ADVERSE CARDIAC AND CEREBROVASCULAR EVENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2017) (0)
- Identification of Low Risk Emergency Patients with Symptoms of Possible Acute Coronary Syndrome: External Validation of the Vancouver Chest Pain Rule (2013) (0)
- H2S‐induced cardiac protection is caused by activation of mTORC2/Akt/Bim pathway in an isolated rat heart ischemia / reperfusion model (2013) (0)
- Effectiveness of MPatcH on Haemostasis and Mobilisation Following Diagnostic and Interventional Cardiology Procedures (2009) (0)
- Assayof Endopeptidase-24. 11 Activityin PlasmaAppliedto In VivoStudiesof Endopeptidase Inhibitors (1992) (0)
- Transcatheter targeted myocardial restoration using hydrogel-based cell-free compound: Toward an adoptable clinical protocol. (2023) (0)
- Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection (2014) (0)
- 4927MicroRNA Let-7d-3p contributes to cardiac protection via targeting HMGA2 (2018) (0)
- Harnessing the Power of “Omics”: Discovering Novel microRNA and Protein Biomarkers of Acute Kidney Injury in Acute Heart Failure (2022) (0)
- Comprar Guía de supervivencia para enfermería hospitalaria | Sharon L. Edwards | 9788480866699 | Elsevier España (2010) (0)
- Plasma Levels of Myeloperoxidase (MPO) and Thiocyanate (SCN-) Predict Mortality in Patients Following Acute Myocardial Infarction (2011) (0)
- How to successfully undertake genetics research in partnership with indigenous maori communities (2011) (0)
- Cardiac lentiginosis. (1990) (0)
- Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis (2022) (0)
- Abstract 11125: Soluble Urokinase Plasminogen Activator Receptor is a Strong Prognostic Indicator of Mortality in Acutely Breathless Patients (2018) (0)
- LONGITUDINAL CHANGES IN N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE: ASSOCIATIONS WITH ECHOCARDIOGRAPHIC CHANGES AND OUTCOMES IN HEART FAILURE FROM THE SHOP AND PEOPLE STUDY (2023) (0)
- Outcomes Among Patients With First-Time Acute Coronary Syndromes in New Zealand: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS) (2021) (0)
- Abstract 206: Incidence and Duration of Atrial Fibrillation Among a Large, Real-World Population of Cryptogenic Stroke Patients with Insertable Cardiac Monitors (2015) (0)
- Natriuretic peptides. (1995) (0)
- A Comparison of Metabolic Risk Profiles Among Rural and Urban Māori in New Zealand (2010) (0)
- Rapid diagnostic protocol for patients with chest pain – Authors' reply (2011) (0)
- Go beyond bias training (2018) (0)
- Colonic crunch: a new physical sign. (1993) (0)
- THE REAL LIFE EXPERIENCE OF EVEROLIMUS ELUTING CORONARY STENT: “THE APPLIANCE OF XIENCE” (2008) (0)
- INCREASED NEUTROPHIL AND MONOCYTE DEGRANULATION WITH RELEASE OF INTRACELLULAR LEUCOCYTE ELASTASE AND MYELOPEROXIDASE IN ACUTE ST ELEVATION MYOCARDIAL INFARCTION (2008) (0)
- Plasma Coenzyme Q10 (CoQ10) is an Independent Predictor of Survival in Chronic Heart Failure (CHF) (2007) (0)
- Abstract 290: Circulating miRNAs as Biomarkers in Acute Coronary Syndrome (2012) (0)
- Diagnosis of Acute Myocardial Infarction in Emergency Patients with Chest Pain Using a Two Hour Algorithm with Highly Sensitive Troponin I Assay Results (2013) (0)
- Soluble Urokinase Plasminogen Activator Receptor Predicts Mortality and Adverse Cardiovascular Outcomes Following Acute Coronary Syndrome (2022) (0)
- Identifying Candidate Protein Markers of Acute Kidney Injury in Acute Decompensated Heart Failure (2022) (0)
- Increased In-Hospital Revascularization After Acute Myocardial Infarction (AMI) is Associated with Improved Long-Term Survival (2007) (0)
- Heart failure DISEASE MONITORING OF PATIENTS WITH CHRONIC HEART FAILURE (2007) (0)
- Can High Sensitivity Troponin Accelerate Current Diagnostic Protocols for the Diagnosis of Acute Myocardial Infarction (2011) (0)
- BNP Signal Peptide is Protective in Ischaemia Reperfusion Injury (2013) (0)
- Connexin 43 expression and conduction velocity are reduced in plakoglobin-deficient mice: Implications for arrhythmogenesis in Naxos disease (2005) (0)
- A decade of improvement in investigations received and treatments delivered to New Zealand (NZ) ST-elevation myocardial infarction (STEMI) patients: Results from the NZACS national audits of 2002, 2007 and 2012 (2014) (0)
- Variation in B-Type Natriuretic Peptide in Ambulatory Subjects with stable Chronic Heart Failure is Associated with Variability in Directly Measured Left Atrial Pressure (2007) (0)
- Is the Mortality Risk Following an Acute Coronary Syndrome (ACS) Admission to a Non-intervention Centre Related to Access to Cardiac Angiography? Eighteen Month Follow-up of the 2002/2007 New Zealand (NZ) ACS Audits (2012) (0)
- The influence of diuretic treatment on the diagnostic utility of BNP in suspected heart failure in the community (2003) (0)
- Plasma Alpha Human Atrial Natriuretic Peptide in Cardiac Impairment (1986) (0)
- A055 Sex Differences in Ventricular Remodeling and Long-Term Heart Failure Outcomes Following Acute Coronary Syndrome (2020) (0)
- MORTALITY EFFECT OF ICD IN PRIMARY PREVENTION OF NON ISCHEMIC CARDIOMYOPATHY: A META ANALYSIS OF RANDOMIZED CONTROL TRIALS (2017) (0)
- Trans-cardiac Production of Urotensin II in Acute and Chronic Ischaemia (2009) (0)
- Improved rates of secondary prevention medication following hospitalisation for an acute coronary syndrome (ACS) in New Zealand (NZ): Results from the NZ ACS national audits of 2002, 2007 and 2012 (2014) (0)
- Abstract 19259: Dynamic Metabolomic Profiling Reveals Evidence for Metabolic Inflexibility in the Failing Heart (2017) (0)
- Effects of BNP Infusion and Neutral Endopeptidase Inhibition in Heart Failure (1997) (0)
- Diagnostic Utility of Mid-Regional Pro–Atrial Natriuretic Peptide in Patients with Heart Failure with Preserved Ejection Fraction (2018) (0)
- Effects of BNP Infusion in Heart Failure (1997) (0)
- ASIA PACIFIC EVALUATION OF CHEST PAIN TRIAL (ASPECT) - NEW ZEALAND ARM (2010) (0)
- Sex differences in ventricular remodeling and long-term heart failure outcomes following acute coronary syndrome (2020) (0)
- Effects of Zinc or Copper Deficiency and Pair- Feeding on Hepatic Leptin Mrna Expression (2003) (0)
- Clinical research Heart failure / cardiomyopathy Urocortin 2 infusion in human heart failure (2007) (0)
- Personalized diagnosis in suspected myocardial infarction. (2023) (0)
- Three year incidence and duration of atrial fibrillation episodes among a large, real-world population of cryptogenic stroke patients with insertable cardiac monitors (2020) (0)
- Improved long-term survival after anterior myocardial infarction treated by direct angioplasty/stenting with remote surgical backup (2003) (0)
- Routine measurement of NT-proBNP and post-discharge clinical outcomes: Initial findings from a randomised controlled trial (2015) (0)
- Letter and Spirit (2018) (0)
- Comparison of Five Accelerated Diagnostic Protocols for Stratification of Patients Presenting with Acute Chest Pain (2017) (0)
- Development and Validation of a Risk Score for Patients Back in the Community After an Acute Coronary Syndrome Event (2018) (0)
- Bivariate assay for cleaved atrial natriuretic factor (ANF(101–105/106–126)) in sheep plasma (1992) (0)
- Bleeding Events in Patients Randomised to Mobilise 4 or 6 h After Percutaneous Coronary Intervention (PCI) (2009) (0)
- N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IN AORTIC STENOSIS: RESULTS FROM THE NZ HEART VALVE STUDY (2008) (0)
- SERIAL DOPPLER ECHOCARDIOGRAPHY AND TISSUE DOPPLER IMAGING MEASUREMENTS CAN ACCURATELY DETECT ELEVATED DIRECTLY MEASURED LEFT ATRIAL PRESSURE IN CHRONIC HEART FAILURE (2008) (0)
- B-PO05-044 IMPROVED DETECTION OF ATRIAL ARRHYTHMIAS WITH REGULAR R-R INTERVALS IN PATIENTS WITH THE LUX-DX INSERTABLE CARDIAC MONITOR (2021) (0)
- Abstract 19648: Amino-Terminal Pro-Brain Natriuretic Peptide Improves Risk Stratification in Asymptomatic Individuals at Very High Risk of Future Cardiovascular Events (2014) (0)
- Sleep Study-Guided Multidisciplinary Therapy for Acute Coronary Syndrome: A Randomized Clinical Trial (2019) (0)
- EFFECT OF SPIRONOLACTONE ON THE PLASMA PROTEOME IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): IMPACT OF BASELINE N-TERMINAL (NT)-PRO B-TYPE NATRIURETIC PEPTIDE (BNP) LEVELS (2023) (0)
- B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation (2010) (0)
- TREATMENT OF ACUTE MYOCARDIAL INFARCTION (AMI) IN 2006 AND 1-YEAR OUTCOMES (2008) (0)
- Titration of medications and outcomes in multi‐ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand (2023) (0)
- Comparison of Intrathoracic Impedance with Direct Left Atrial Pressure in Chronic Heart Failure (2008) (0)
- Left Ventricular Ejection Fraction in Addition to N-Terminal Pro–B-Type Natriuretic Peptide for Risk Stratification in the Ambulant Elderly (2011) (0)
- Beating the bushes for biomarkers (2020) (0)
- A017 Cardiac Biomarkers to Guide Risk in Secondary Prevention Post-Acute Coronary Syndromes (2020) (0)
- Incidence of Atrial Fibrillation within One Year of Cryptogenic Stroke among a Large, Real-World Population with Insertable Cardiac Monitors (S42.003) (2016) (0)
- Effects of Hypertrophic and Dilated Cardiac Geometric Remodeling on Ejection Fraction (2022) (0)
- Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN‐HF Registry (2021) (0)
- Chronic obstructive pulmonary disease in heart failure: influence on circulating biomarkers and outcome (2020) (0)
- Novel Oxidative Stress Biomarkers with Risk Prognosis Values in Heart Failure (2023) (0)
- P2616Soluble urokinase plasminogen activator receptor (suPAR) predicts 1 year mortality in patients with acute breathlessness (2019) (0)
- INTRA-AORTIC BALLOON COUNTER-PULSATION USE AT TWO TERTIARY REFERRAL CENTRES IN THE SOUTH ISLAND (2008) (0)
- Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction (2021) (0)
- Adrenomedullin infusion in subjects with essential hypertension (2000) (0)
- DIAGNOSTIC DE L'ANGOR INSTABLE (2017) (0)
- Urocortin 1 exhibits potent inhibition of cardiac sympathetic nerve activity in ambulent sheep (2007) (0)
- Abstract 12170: Chromosome 1q41 and 3q22.3 Coronary Artery Disease Risk Loci are Associated with Altered Cardiac Gene Expression Profiles in Normal and Diseased Heart (2011) (0)
- Response to: ‘Convalescent troponin and cardiovascular death following acute coronary syndrome’ by Kawada (2020) (0)
- unrestricted subjects . pulmonary artery pressure in Continuous recording of (0)
- P4639Plasma tissue factor coagulation activity in post-acute myocardial infarction patients (2019) (0)
- CHAPTER 39 – Endocrine Causes of Hypertension (2010) (0)
- CHRONIC CONGESTIVE HEART FAILURE EXERCISE TESTING IN THE ASSESSMENT OF (2002) (0)
- Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 2-Year Cardiovascular Events in Patients After Acute Chest Pain (2020) (0)
- Atrial fibrillation and the prognostic performance of biomarkers in heart failure (2020) (0)
- Material property alterations for phenotypes of heart failure with preserved ejection fraction: A numerical study of subject-specific porcine models (2022) (0)
- Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts Mortality in Patients With Acute Chest Pain (2021) (0)
- Does NT-proBNP testing reduce costs and improve accuracy in the diagnosis of heart failure? (2007) (0)
This paper list is powered by the following services:
Other Resources About A. Mark Richards
What Schools Are Affiliated With A. Mark Richards?
A. Mark Richards is affiliated with the following schools:
